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Abstract 
The vascular adventitia is recognized as a dynamic mediator of vascular structure 
and function, yet its role in aging is not understood. The purpose of this thesis was to 
examine the age-related changes of the vascular adventitia and determine the underlying 
mediators responsible. Male Sprague-Dawley rats were aged to 15, 30, 50 and 80 weeks 
before being anesthetised and euthanized by exsanguination. Thoracic aortas, mesenteric 
and pudental arteries were isolated, formalin fixed, and embedded in paraffin then 
sectioned at 5μm. Vessels were examined by microscopy and protein expression was 
determined by indirect immunofluorescence. The thickness of the adventitia increased 
dramatically with age. Immunofluorescence revealed a robust expression of endothelin 
system proteins in the adventitia. Additionally, extracellular matrix proteins collagen and 
fibronectin, and the proliferation marker Ki67 showed strong adventitial origin. The 
changes observed in the vascular adventitia with aging clearly demonstrate an important 
role in the process of vascular aging. 
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1: Introduction 
 Although considered for a long time to be merely a passive structural support for 
the blood vessel wall, the vascular adventitia has now gained attention in cardiovascular 
research as a potentially critical location for the progression of chronic disease (Rey & 
Pagano, 2002; Sartore, et al., 2001; Siow & Churchman, 2007). Recent work has revealed 
the vascular adventitia to be a dynamic tissue capable of participating in disease 
progression through direct cellular activities and the release of cytokines to act on 
neighbouring cell types (An, Boyd, Wang, Qiu, & Wang, 2006; Dourron, et al., 2005; 
Garanich, Mathura, Shi, & Tarbell, 2007). The vascular adventitia thus serves as a 
potentially untapped wellspring of scientific discovery that could lead to the development 
of novel treatment strategies for an array of cardiovascular diseases. 
 Cultured vascular adventitial fibroblasts have been shown to produce and release 
the potent vasoactive peptide endothelin-1 (ET-1) (An, et al., 2006). ET-1 is commonly 
implicated in chronic vascular diseases such as hypertension and atherosclerosis. Its 
effects on the vasculature are widespread, mediating vascular smooth muscle cell 
(VSMC) contraction (Yanagisawa, et al., 1988), extracellular matrix (ECM) deposition 
(An, et al., 2007; Rodriguez-Vita, et al., 2005), vascular cell proliferation (Dong, et al., 
2005; Milan, et al., 2006), migration (Milan, et al., 2006), and hypertrophy. Conventional 
wisdom in cardiovascular research has suggested that the production and release of ET-1 
is dependent upon the endothelium. However, if these responses are dictated by the 
vascular adventitia, these results may represent the beginning of a paradigm shift in the 
orientation of cardiovascular research from an inside-out view to an outside-in view. 
 Additionally, the vascular adventitia has been implicated in numerous structural 
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and functional changes in the vasculature, both in health and disease. When exposed to 
shear stress, adventitial fibroblasts were shown to have enhanced migratory properties, 
which could contribute to neointimal proliferation (Garanich, et al., 2007). Furthermore, 
removal of the adventitia severely diminished nitric oxide (NO)-dependent vasodilation, 
suggesting a paracrine role of the adventitia in vessel relaxation (Beranova, et al., 2005). 
In addition, adventitial application of a NADPH oxidase inhibitor reduces neointimal 
proliferation, suggesting the adventitia plays a significant role in atherosclerosis (Chan, et 
al., 2007). Clearly, the adventitia is an important location when considering chronic 
vascular diseases. 
 The process of vascular aging is associated with a tremendous increase in the 
incidence and prevalence of numerous chronic vascular diseases. The vasculature 
commonly undergoes structural and functional changes during aging which directly 
contribute to pathology (Greenwald, 2007; Izzo & Mitchell, 2007). Many of these 
structural and functional changes mirror changes which occur in the adventitia in 
response to various injurious stimuli. However, the role that the adventitia plays in 
vascular aging and contributes to age-related vascular diseases is still unknown. The 
purpose of this thesis is to elucidate the specific effects of aging on the vascular 
adventitia, both structurally and functionally. In doing so, we hope to reveal the role of 
the vascular adventitia in the age-related decline in vascular function. 
 
1.1: The Arterial Tree 
 The vasculature is a diverse system of conduits which modulate the cyclical 
pumping of blood produced by the heart. Due to the reciprocal pumping activity of the 
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heart, the blood vessels must be able to dampen the acute pressure increases achieved at 
the end of systole in order to produce constant blood flow to the tissues (Greenwald, 
2007). Further down the line, the muscular and resistance arteries must dilate and 
contract to regulate local blood pressure effectively and to maintain the minimal pressure 
needed to keep blood flowing through the entire systemic circulation (Greenwald, 2007). 
A disruption of this process in any of these vascular beds results in stiffening of the 
vessels and an increase in blood pressure. 
 
1.1.1: Aorta & Central Elastic Conduit Arteries 
The elastic conduit arteries comprise the thoracic and abdominal aorta, the carotid 
artery, and the pulmonary arteries. These vessels are the first conduits through which the 
blood flows after being ejected by the ventricles. As such, these vessels are exposed to 
the highest temporal blood pressure changes in the entire vascular tree. Due to the very 
high pressure bolus of blood that each of these vessels receives at end systole, these 
vessels are highly elastic, and are able to dampen the pressure changes (Greenwald, 
2007). The resultant expansion of the aorta during end systole stores kinetic energy and 
propels the blood throughout the systemic circulation through the duration of diastole 
(Greenwald, 2007). As such, the proximal aorta may be considered to be the third 
pumping chamber of the heart (Izzo & Mitchell, 2007). 
During aging, the elastic conduit arteries commonly stiffen, losing the elasticity 
with which they are able to effectively control systemic blood pressure. This stiffening is 
due to a number of changes, both metabolic and structural. Chief among these changes 
are the deposition of collagen and breakdown of elastin fibres, calcification of the 
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vessels, enhanced activity of matrix metalloproteinases (MMPs), accumulation of 
advanced glycation end-products (AGEs), endothelial cell (EC) dysfunction, and VSMC 
proliferation and hypertrophy (Greenwald, 2007). 
During aging, the aortic wall undergoes substantial stiffening, which may be the 
result of an overall thickening of the vascular wall. This appears to be achieved through 
smooth muscle cell hypertrophy (Connat, et al., 2001). Additionally, with age the medial 
smooth muscle layer of rats becomes increasingly disorganized and irregular, displaying 
a characteristic folding of the elastic lamellae between smooth muscle cell layers 
(Connat, et al., 2001). Similarly, carotid artery intima-media thickness increases 
substantially with age in humans (Tanaka, Dinenno, Monahan, DeSouza, & Seals, 2001). 
This increase in carotid thickness can be attributed to local elevations in systolic blood 
pressure (Tanaka, et al., 2001). Furthermore, advancing age is significantly associated 
with decreased compliance and distensibility of the aorta, but showed no effect in the 
muscular brachial artery (van der Heijden-Spek, et al., 2000). It would appear that the 
distending pressure exerted by local elevations in blood pressure commonly observed in 
aging is sufficient to invoke a hypertrophic response in the large elastic arteries. 
A possible mechanism for the thickening of elastic arteries is an activation of 
inflammatory processes with aging. C-reactive protein (CRP), a marker of cellular 
inflammation, was shown to be elevated in elderly patients, and correlated well with 
aortic stiffness (Nakhai-Pour, Grobbee, Bots, Muller, & van der Schouw, 2007). Even 
when adjusted for traditional risk factors such as smoking and cholesterol levels, CRP 
significantly predicted increased pulse-wave velocity in these subjects (Nakhai-Pour, et 
al., 2007). Furthermore, activity of MMP-2 was significantly enhanced in the aortas of 
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aged subjects (McNulty, Spiers, McGovern, & Feely, 2005). However, the activity of 
MMP-2 was unchanged with aging in the internal mammary artery (McNulty, et al., 
2005). Additionally, in the F344xBN F1 hybrid rat model, a significant increase in 
inflammation related molecules was observed, including the adhesion molecules inter-
cellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-
1), as well as the bone morphogenic proteins osteopontin and bone sialoprotein-1 (S. J. 
Miller, et al., 2007). In addition to this, the markers of oxidative stress 8-isoprostane and 
3-nitrotyrosine were also increased with aging (S. J. Miller, et al., 2007). It would appear 
that the age-related structural changes observed in the large elastic conduit arteries are 
mediated at least in part by inflammation and oxidative stress, but these changes are not 
necessarily observed in smaller muscular arteries further along the arterial tree. 
 
1.1.2: Mesenteric & Peripheral Muscular Arteries 
 The muscular arteries comprise the blood vessels which are immediately distal to 
the large elastic conduit arteries in the arterial tree. These arteries are characterized by 
their greater degree of smooth muscle tone, and an increasing ratio of collagen to elastin 
content in the ECM (Greenwald, 2007; Izzo & Mitchell, 2007). As a result, these arteries 
are more sensitive to acute changes in vascular tone, and are often considered to be the 
most important mediators of essential hypertension (Schiffrin, 2003). Due to their wide 
distribution around the body and their substantial muscular tone, these arteries have the 
ability to control peripheral resistance and hypertension (Schiffrin, 2003). 
 In rat mesenteric arteries, aging induces a significant increase in medial thickness 
and pulse pressure despite no changes to lumen diameter (Moreau, d'Uscio, & Luscher, 
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1998). The same arteries exhibited a blunted vasomotor response to Ang II, but no 
change in sensitivity to either epinephrine or ET-1 (Moreau, et al., 1998). Furthermore, it 
would appear that the constrictor role of ET-1 in small mesenteric arteries is mediated 
entirely by the ETA receptor (Mickley, Gray, & Webb, 1997; Rizzoni, et al., 1997). Given 
our knowledge of angiotensin II (Ang II) signalling being mediated in part by ET-1 
production and release (An, et al., 2006; An, et al., 2007), it is tempting to speculate the 
changes in Ang II sensitivity with age are reflected in the ability of the vessel to produce 
ET-1. Interestingly, it has been hypothesized that angiotensin AT2 receptor activity may 
switch to more constrictor roles in aging (Widdop, Vinh, Henrion, & Jones, 2008). 
However, earlier reports noted an increase in aortic ET-1 mRNA production with 
increasing age (Kumazaki, Fujii, Kobayashi, & Mitsui, 1994; Tokunaga, et al., 1992). 
Clearly, this demonstrates the variability in the activity of the vasculature at different 
points in the vascular tree. 
 Interestingly, the adventitia appears to play a significant role in small artery 
remodelling with increasing age. The amount of collagen deposition was significantly 
enhanced with aging in rat mesenteric arteries (Briones, Salaices, & Vila, 2007). This 
would be in agreement with findings demonstrating increased thickness and stiffness of 
aged mesenteric arteries in rats (Laurant, Adrian, & Berthelot, 2004). This study also 
found an overall decrease in systolic and diastolic blood pressure with age, resulting in 
lower mean arterial pressure. However, the researchers also noted a significant increase 
in pulse pressure with age, suggesting that the reduced distensibility of the mesenteric 
arteries was contributing to larger variation in blood pressure (Laurant, et al., 2004). 
Interestingly, previous work has shown that pulse pressure is correlated with 
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media/lumen ratio of resistance arteries in elderly patients independent of other common 
blood pressure measures (James, Watt, Potter, Thurston, & Swales, 1995). It would seem 
that high pulse pressure, a hallmark of large elastic artery stiffening, plays a role in small 
artery remodelling. 
 An important characteristic of small muscular arteries is their ability to control 
peripheral resistance through the regulation of vascular tone. With increasing age, it was 
found that the ET-1 mediated vasoconstrictor tone was enhanced in men (Van Guilder, 
Westby, Greiner, Stauffer, & DeSouza, 2007). This increased vasoconstrictor tone 
appeared to be mediated greatly by ETA receptor stimulation, a finding that is confirmed 
in animal studies (Mickley, et al., 1997; Rizzoni, et al., 1997). Interestingly, 
prehypertensive renin-angiotensin-aldosterone system (RAAS) blockade results in long-
term amelioration of vascular function and structural changes (Baumann, et al., 2007). 
This blockade also resulted in an enhanced expression of endothelial NO synthase 
(eNOS) in the vasculature, suggesting a further mechanism for the amelioration of blood 
pressure augmentation through antihypertensive treatment (Baumann, et al., 2007). 
Furthermore, the enhanced ET-1 mediated vasoconstrictor tone observed in aging was 
ameliorated through aerobic exercise training, revealing another mechanism for the long-
term augmentation of vascular tone in small arteries (Van Guilder, et al., 2007). It would 
appear that the long-term elevation in blood pressure in aging mediated by small artery 
remodelling has numerous causes and similarly may be ameliorated through numerous 
treatments. 
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1.1.3: Pudendal & Small Resistance Vessels 
 The small resistance vessels comprise the arterioles and capillaries that are 
responsible for gas, nutrient and waste exchange in the cardiovascular system. These 
vessels have the smallest diameter of any vessel in the body (arbitrarily defined as any 
vessel less than ~300μm in diameter), and thus may provide the greatest amount of 
resistance to blood flow (Mitchell, 2008). As with the peripheral muscular arteries, the 
regulation of blood flow and pressure in the resistance vessels is accomplished through 
local mediators. As such, the degree of vascular smooth muscle tone in these vessels is 
paramount in the maintenance of blood flow and pressure (Mitchell, 2008). 
 As with the vasculature as a whole, the reactivity of the small resistance vessels 
varies by location (J. M. Muller-Delp, 2006). In aging, the effects of various stimuli 
differ between the vascular beds of different organ systems (J. M. Muller-Delp, 2006). 
Additionally, the reactivity of resistance vessels of a single organ system such as the 
skeletal muscle varies by muscle and fibre type distribution (J. M. Muller-Delp, 2006). 
For instance, vasodilation to acetylcholine (ACh) is reduced in soleus muscle feed 
arteries and first order arterioles of aged rats (Woodman, Price, & Laughlin, 2002) 
however, ACh-induced vasodilation is not affected by aging in gastrocnemius muscle 
feed arteries and first order arterioles (J. Muller-Delp, et al., 2002). 
 Similarly, alterations in vasoactive mediator reactivity are common among 
resistance vessels in aging. The Ang II AT2 receptors mediate vasoconstriction and 
reactive oxygen species (ROS)  production in aged rats, but produce the opposite effects 
in young rats (Pinaud, et al., 2007). Additionally, the vasoconstrictive effects of ET-1 in 
small subcutaneous arteries are mediated entirely by ETA receptors in aged patients, but 
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may be mediated by both the ETA and ETB receptors in younger patients (Porteri, et al., 
2002). Furthermore, intraluminal shear stress may induce eNOS mRNA expression and 
potentiate ACh-mediated vasodilation in the soleus feed arteries of old rats, but has a 
much lower effect in young rats (Woodman, Price, & Laughlin, 2005). 
 It is important to note that although the effects of aging in the vasculature may 
vary by location in the arterial tree, the changes occurring in one location will ultimately 
affect another location due to alterations in blood flow and pressure (Mitchell, 2008). For 
instance, the stiffening of the central elastic conduit arteries may have a direct effect on 
systolic blood pressure through augmentation of pulse wave velocity. This elevation in 
blood pressure forces more blood to flow through the distal vasculature which may lead 
to hypertrophic remodelling of the peripheral muscular arteries and resistance vessels 
(Mitchell, 2008). This in turn may result in increased peripheral vascular resistance, 
which may further elevate blood pressure, and lead to further hypertrophic remodelling 
and stiffening of the central elastic conduit arteries (Mitchell, 2008). So, although there 
may exist discrete differences in the effects of aging on varying isolated regions of the 
arterial tree, when combined these individual effects may inevitably lead to the same end 
result. 
 
1.2: Anatomy of the Arterial Wall 
 The blood vessels can be described as continuous conduit tissue comprised of 
three distinct layers, the tunica intima, the tunica media, and the tunica adventitia. Each 
of these layers plays unique roles in the structural and functional maintenance of the 
blood vessel wall, both in health and disease. The innermost layer of the blood vessel is 
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termed the tunica intima, and is normally comprised of a single layer of ECs. This layer 
provides direct contact with the bloodstream and is critically important for endocrine 
signalling, gas exchange, and waste removal from the vascular wall (Martini, 
Bartholomew, & Ober, 2003). The middle layer is separated from the tunica intima by the 
internal elastic lamina and is termed the tunica media. This layer is the most prominent in 
the vessel wall, comprises mainly VSMCs, and is chiefly responsible for the maintenance 
of vascular tone (Martini, et al., 2003). The external elastic lamina separates the tunica 
media from the outermost layer of the blood vessel, termed the tunica adventitia. This 
layer is primarily composed of fibroblasts, but may contain numerous other cell types, 
including macrophages, nerve terminals, and stem cells (Hoshino, Chiba, Nagai, Ishii, & 
Ochiai, 2008; Rey & Pagano, 2002; Sartore, et al., 2001). Beyond the tunica adventitia is 
a layer of perivascular fat which generally provides insulation and lubrication for the 
large arteries, but may also be involved in vascular signalling cascades (Barandier, 
Montani, & Yang, 2005) 
 
1.2.1: The Vascular Adventitia 
 For years the vascular adventitia was thought to be simply a passive structural 
support for the vessel wall, producing ECM and providing a location for the residence of 
terminal nerve fibres (Gutterman, 1999; Sartore, et al., 2001). Recent work has revealed 
the adventitia to be a dynamic mediator of vascular structure and function, both in health 
and disease. 
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1.2.1.1: Cellular Composition 
 While the tunica intima and tunica media are mainly composed of ECs and 
VSMCs, the primary cell type in the adventitia is the fibroblast, which does not express 
α-smooth muscle actin (α-SMA), myosin, nor desmin under normal conditions. 
However, under certain pathological conditions (e.g. balloon injury) these fibroblasts are 
activated and proliferate. These previously α-SMA-negative fibroblasts now express α-
SMA and myosin, and transdifferentiate into myofibroblasts. Although they express α-
SMA, myofibroblasts do not express markers of highly differentiated VSMCs, such as 
desmin and smoothin (Ronnov-Jessen & Petersen, 1993; Schmitt-Graff, Desmouliere, & 
Gabbiani, 1994). The adventitia exhibits few VSMCs, ECs (Sartore, et al., 2001), 
leukocytes (Capers, et al., 1997), and ganglionic cells (Rey & Pagano, 2002), but may 
contain stem cells (Hoshino, et al., 2008). Figure 1 displays the arrangement of the vessel 
wall and outlines the cellular composition of each layer. 
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Figure 1. Anatomy and cellular composition of the blood vessel. The tunica intima, composed mainly of 
endothelial cells, is separated from the tunica media, composed mainly of vascular smooth muscle cells, by 
the internal elastic lamina (IEL). The external elastic lamina (EEL) separates the tunica media from the 
tunica adventitia, which is composed of fibroblasts, myofibroblasts, and macrophages, as well as some 
vascular progenitor cells, and stem cells. Also contained within the adventitia are the vascular terminal 
nerve fibres. External to the adventitia is a layer of perivascular fat. 
 
1.2.1.2: Vasomotor Responses 
 Evidence suggests that the vascular adventitia may play an important role in 
maintaining vascular tone under physiological and pathophysiological states. First, it has 
been demonstrated that NO derived from adventitial inducible NO synthase (iNOS) can 
regulate smooth muscle function. Interestingly, results from Kleschyov et al. (1998) 
demonstrate that the adventitia is a richer source of NO than the media, and that the 
adventitia-derived NO is able to activate guanylyl cyclase and vasodilatation within the 
media of the rat aorta (Kleschyov, et al., 1998). Recently, it was reported that the 
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adventitia is able to produce a ‘NO-like’ compound that is able to mediate VSMC 
function in endothelium-denuded rat aortas (Beranova, et al., 2005). 
Second, the ability of the adventitia to respond to vasoactive peptides has been 
discovered recently in human tissue-engineered blood vessels. The results indicate that 
the engineered adventitia is able to contract after endothelin-1 (ET-1) treatment, a result 
that was independent of the medial layer and mediated through the ETA receptor 
(Laflamme, et al., 2006). Additionally, the tissue-engineered adventitia dilates in 
response to sodium nitroprusside (SNP) administration (Laflamme, et al., 2006). As a 
result, the adventitia of the blood vessel may indeed play a significant role in the 
modulation of vascular tone as it has been demonstrated that both vasoconstriction and 
vasodilatation can occur in an adventitia-dependent manner.   
Third, the adventitial ROS may also play a role in regulating vascular contractile 
responses. Considerable evidence has indicated that oxidative stress can regulate vascular 
tone. In Ang II-induced hypertension and spontaneously hypertensive rats, ACh-induced 
endothelium dependent relaxation is impaired (Park, Touyz, Chen, & Schiffrin, 2002; 
Rajagopalan, et al., 1996).  Interestingly, superoxide dismutase (SOD) markedly 
increases peak relaxation in response to ACh in vessels from Ang II-treated animals 
(Rajagopalan, et al., 1996). Consistent with the above findings is the observation by 
Wang et al. (1999) that adventitial superoxide (.O2-) is increased dramatically in the Ang 
II-infused hypertensive model (Wang, et al., 1999). Additionally, it was found that the 
enhanced .O2- production gives rise to spontaneous myogenic contractions (Ghosh, Wang, 
& McNeill, 2004; Wang, et al., 1999).  Strikingly, removing the adventitia from large 
arteries reduces VSMC contractile responses and enhances endothelium-dependent 
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relaxation (Gonzalez, Arribas, Molero, & Fernandez-Alfonso, 2001). These findings are 
consistent with the hypothesis that increased .O2- generation, including that by the 
adventitia, inactivates NO (Karasu, 2000; Wattanapitayakul, Weinstein, Holycross, & 
Bauer, 2000), and since the diffusion distance for NO is on the order of 30 µm, it is 
capable of pervading the entire vascular wall (Beckman, 1996). Moreover, .O2- can 
generate hydrogen peroxide (H2O2), evoking a loss of endothelial function (Walia, 
Sormaz, Samson, Lee, & Grover, 2000), thereby inhibiting ACh-induced relaxation and 
contributing to exaggerated vasoconstrictor responses (Shastri, Gopalakrishnan, Poduri, 
& Wang, 2002; Wattanapitayakul, et al., 2000). These data strongly support the 
hypothesis that the vascular adventitia may indeed play a significant role in the 
modulation of vascular tone. The role of the adventitia in regulating vascular tone 
through ET-1 expression and NO production is illustrated below in Figure 2. 
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Figure 2. Role of the vascular adventitia in endothelin-1 expression and vasomotor regulation. The 
endothelin converting enzyme-1 (ECE-1) expressed in the adventitia produces endothelin-1 (ET-1) which 
may act directly in the adventitia, resulting in extracellular matrix (ECM) deposition, fibroblast (FB) 
proliferation, and migration, or may diffuse to the media to produce vascular contraction, cell growth, and 
proliferation. Similarly, the tunica intima is also a rich source of ET-1, but here may act on endothelial ETB 
receptors, activating endothelial nitric oxide synthase (eNOS) and the release of nitric oxide (NO), which 
mediates dilatation in the vascular smooth muscle. ET-1 signalling in the media and adventitia results in 
reactive oxygen species (ROS) production, which may react with NO, thereby reducing its bioavailability. 
 
1.2.1.3: Role in Vascular Diseases 
The vascular adventitia has gained increasing attention as a possible source and 
cause of vascular diseases, as well as a potential target for therapy. Recent evidence has 
implicated the vascular adventitial fibroblasts and myofibroblasts in the aetiology and 
progression of hypertension and atherosclerosis (Chan, et al., 2007; Dourron, et al., 2005; 
Garanich, et al., 2007; Gonzalez, et al., 2001; Laflamme, et al., 2006; G. Li, Chen, Oparil, 
Chen, & Thompson, 2000; L. Li, Zhu, Shen, & Gao, 2006; Liu, Ormsby, Oja-Tebbe, & 
 16 
 
Pagano, 2004; Shi, O'Brien, et al., 1996). Interestingly, each of these vascular diseases is 
highly prevalent among aged populations (Hajjar, Kotchen, & Kotchen, 2006; Minamino 
& Komuro, 2002), lending credence to the possibility of a cardiovascular aging syndrome 
of adventitial origin. This evidence may be illustrative of the ability of the vascular 
adventitial fibroblasts to alter the vascular milieu in aging, and contribute to age-
dependent stiffening of the arteries. These mechanisms in turn contribute to the 
progression of hypertension and atherosclerosis. 
After intimal injury, the adventitia contributes to the formation of atherosclerotic 
lesions (Torsney, Hu, & Xu, 2005). In addition to migrating to the site of lesion, the 
adventitial fibroblasts also release cytokines, recruiting macrophages and monocytes 
which contribute to further formation of atherosclerotic lesions (Maiellaro & Taylor, 
2007). In the context of a hyperlipidemic state, the recruitment of macrophages and 
monocytes contribute by forming foam cells and oxidizing lipids (Maiellaro & Taylor, 
2007). 
In addition to the formation and exacerbation of atherosclerotic plaques, the 
adventitia can also be involved in stabilizing the vessel through vasa vasorum 
neovascularisation (Ritman & Lerman, 2007). When the atherosclerotic lesion forms, and 
a plaque results, the vessel lumen becomes greatly reduced. To compensate for this 
reduction of blood flow and nutrient supply through the vessel lumen, the vessel forms 
vasa vasora, which are tiny vessels that provide the vessel itself with blood supply 
(Ritman & Lerman, 2007). Typically vasa vasora are only found in large vessels in which 
the diffusion of nutrients and waste products through the entire vessel wall is difficult or 
impossible (Ritman & Lerman, 2007). In atherosclerosis, the new formation of vasa 
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vasora can occur, providing the vessel with blood flow after the lumen has been 
occluded. Under hypoxic conditions normally encountered in atherosclerosis, the 
adventitia is stimulated to release ET-1 (Davie, et al., 2006). ET-1 then acts on the vasa 
vasora ECs to promote neovascularisation, providing the occluded vessel with blood flow 
(Davie, et al., 2006). As a side effect, the newly formed vasa vasora serves as a conduit 
for further macrophage and monocyte migration to the atherosclerotic lesion (Maiellaro 
& Taylor, 2007). As a result, the atherosclerotic plaque is further exacerbated, and 
stabilized by vasa vasorum neovascularisation. 
 The vascular adventitia is well positioned to offer a site for the application of 
treatments in order to ameliorate the effects of its reactive constituents. Being located on 
the extreme exterior of the blood vessel, the adventitia allows direct application of 
pharmaceutical and genetic interventions. Thus far, most of these treatments have 
revolved around inhibiting the NADPH oxidase system, since this system has been 
shown to be integral in the regulation of adventitial activation (An, et al., 2007). Chan, et 
al. (2007) showed that the adventitial application of apocynin (a NADPH oxidase 
inhibitor) reduces neointima formation and endothelial dysfunction in rabbit carotid 
arteries. This study, though presenting intriguing results, does not provide definitive 
evidence of the adventitia acting alone in causing neointima formation and endothelial 
dysfunction. It does however present evidence of an effective adventitial delivery system 
that shows a clear improvement in endothelial function compared with more commonly 
used techniques (Chan, et al., 2007). At the very least, this study provides further in vivo 
evidence illustrating the importance of the adventitia in disease processes. In addition to 
this study, work with the angiotensin receptor blocker losartan has shown success in 
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reducing neointimal hyperplasia in porcine arteries (Moon, Molnar, Yau, & Zahradka, 
2004). Application of losartan in fibrin glue to the exterior of balloon injured vessels 
showed a large significant decrease in the amount of ECs growing in the artery (82%), as 
well as a great reduction in the proliferation of new ECs (97%). This study positively 
confirms the importance of angiotensin signalling in the adventitia leading to vascular 
disorders like neointimal hyperplasia. 
 Further work has examined the introduction of gene therapies to down-regulate 
the activity of adventitial NADPH oxidase in the vessels. For instance, Liu et al. (2004) 
showed that the introduction of a viral vector containing the NADPH oxidase inhibitor 
gp91ds was able to attenuate VSMC hypertrophy in mouse carotid arteries under Ang-II 
stimulation. As a result of the treatment, the VSMC area remained similar to control 
conditions, however systolic blood pressure was not returned to control levels (Liu, et al., 
2004). The same group also showed that the gp91ds NADPH oxidase inhibitor could also 
be used to attenuate neointimal formation after balloon injury in rat carotid arteries 
(Dourron, et al., 2005). Using a very similar dominant-negative p67phox construct, Weaver 
et al. (2006) were also able to attenuate neointimal hyperplasia in rat carotid arteries. This 
study also utilized a balloon injury model to induce neointimal formation, and as such 
may not be directly applicable to chronic disease models of atherosclerosis causing 
endothelial damage. Nonetheless, the introduction of a natively expressed inhibitor of 
NADPH oxidase has shown to be effective in reversing the detrimental activities of the 
adventitia normally found in chronic disease models (Weaver, et al., 2006). 
 The main drawback of perivascular treatment strategies is the invasive nature of 
exposing the vessel. Unfortunately there is no effective method for applying a drug or 
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gene therapy to the exterior of a blood vessel without making a serious incision in the 
patient. The most readily applicable avenue for the use of perivascular treatments would 
be in vascular surgery procedures, where the vessel has already been exposed, and the 
application of the treatment preparation is simply elementary. 
 
1.3: The Role of Endothelin-1 in Vascular Function 
 
1.3.1: ET-1 Biosynthesis  
The ET family of peptides consists of three distinct isoforms, which each 
comprise 21 amino acids. The predominant isoform produced by the vascular 
endothelium is ET-1 (Yanagisawa, et al., 1988). ET-2 is primarily associated with tumor 
growth and invasion, whereas the majority of ET-3 is localized to the brain and intestine 
(Grimshaw, Wilson, & Balkwill, 2002).  The biosynthesis of the mature ET-1 peptide 
begins with the production of a 200 amino acid precursor termed preproET-1. An 
endopeptidase then cleaves prepro-ET-1 into a 40 amino acid peptide termed bigET-1, 
which is biologically inactive. Finally, the endothelin converting enzyme-1 (ECE-1) then 
cleaves bigET-1 into the biologically active mature 21 amino acid peptide, ET-1 (Blais, 
et al., 2002). The mature ET-1 peptide is approximately 140 times more potent in the 
vasculature as a vasoconstrictor than bigET-1 (Rubanyi & Polokoff, 1994).  
Additionally, it has been shown that MMP-2 may cleave bigET-1 to form a 32 
amino acid form of ET-1 (1-32), which displays greater vasoconstrictive effects than that 
of big-ET-1 (Fernandez-Patron, Radomski, & Davidge, 1999). Furthermore, the big ET-1 
precursor peptide may also be cleaved by a chymase, producing a 31 amino acid peptide, 
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ET-1 (1-31). However, it has been reported that ET-1 (1-31) is most likely bioconverted 
into the 21 amino acid mature ET-1 since both peptides share similar characteristics 
(Fecteau, et al., 2005). Once synthesized mature ET-1 peptide is rapidly degraded, 
displaying a half-life of approximately 1-minute after intravenous injection into the rat 
(Sirvio, Metsarinne, Saijonmaa, & Fyhrquist, 1990).  As such, the activity of ET-1 as a 
vasoactive mediator is primarily through autocrine and paracrine signalling, since 
circulating ET-1 is rapidly cleared.  
 
1.3.2: ECE-1 
 ECE-1 is the main enzyme responsible for the conversion of bigET-1 to ET-1 
(Ohnaka, Takayanagi, Nishikawa, Haji, & Nawata, 1993). ECE-1 was first identified as a 
membrane-bound enzyme (Ahn, Beningo, Olds, & Hupe, 1992), however researchers 
have since identified at least 5 distinct splice variants, which may be localized 
intracellularly, or may lack a transmembrane domain (A. R. Hunter & Turner, 2006; 
Klipper, Levy, Gilboa, Muller, & Meidan, 2006). In human ECs, it was found that the 
predominant localization of ECE-1 was in small intracellular vesicles called Weibel-
Palade bodies (Russell, Skepper, & Davenport, 1998). Similarly, in human and rat 
VSMCs, the predominant localization of ECE-1 was on the surface of α-SMA filaments 
(Barnes & Turner, 1999). It would appear from these experiments that the membrane 
form of ECE-1 is not the most common isoform, thus suggesting an autocrine/paracrine 
signalling modality of ET-1, rather than dispersion in the bloodstream. 
 The activity of ECE-1 has been implicated in vascular disease states. Cytokines 
such as tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) induce the activity of 
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ECE-1 in VSMCs (Woods, et al., 1999). These same cytokines are commonly involved in 
inflammatory and proliferatory signalling in atherosclerosis. Furthermore, it was found 
that ECE-1 protein is abundantly present in atherosclerotic plaques, and may regulate the 
progression of this disease (Ihling, et al., 2001). Additionally, it was found that ECE-1a 
and ECE-1c isoforms were localized to both VSMCs and macrophages in atherosclerosis 
(C. D. Jackson, Barnes, Homer-Vanniasinkam, & Turner, 2006). This would suggest a 
pivotal role for ECE-1 in the signalling and regulation of atherosclerosis. Potentially, an 
up-regulation of ECE-1 activity under atherosclerotic conditions may contribute to cell 
proliferation and the maintenance of vascular tone even in subclinical manifestations of 
the disease (Ihling, et al., 2001). Interestingly ECE-1 presents another novel target for the 
treatment of chronic vascular diseases (Grantham, et al., 2000). 
 More recent work in ECE-1 research has focussed on the specific subcellular 
localization and regulation of different isoforms and their relation to normal vascular 
function as well as disease. The ECE-1b, ECE-1c, and ECE-1d isoforms were found to be 
constitutively phosphorylated in vivo when expressed in Chinese hamster ovary cells 
(MacLeod, Husain, Gage, & Ahn, 2002). Interestingly, it was suggested that a differential 
phosphorylation of ECE-1 isoforms may regulate which substrate is cleaved by the 
isoform in each subcellular localization, since each ECE-1 isoform has its own pH 
optimum, as do its different substrates such as bradykinin, substance P, and bigET-1 
(MacLeod, et al., 2002). 
 Further study has revealed that specific ECE-1 isoforms may be localized to the 
nuclear compartment (Jafri & Ergul, 2003). Interestingly, under high glucose conditions, 
the expression pattern of ECE-1 shifted from the plasma membrane to intracellular 
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locations including the nucleus (Jafri & Ergul, 2003). This would suggest that the 
intracellular localization of different ECE-1 isoforms may be dependent on the metabolic 
state of the cell, and regulation of the localization may differ under pathological 
conditions. Further work has shown that phosphorylation of different isoforms may play 
a role in subcellular localization (Jafri & Ergul, 2006). Although phosphorylation is not 
necessary for ECE-1 to be active, this may play a role in regulating the intracellular 
signalling pathways associated with ET-1 signalling. 
 
1.3.3: ET-1 
 Endothelin-1 (ET-1) is a potent 21 amino acid vasoactive peptide produced in the 
vasculature mainly by endothelial cells (Yanagisawa, et al., 1988). First described by 
Hickey et al (1985) and isolated by Yanagisawa et al (1988), ET-1 has quickly gained 
attention in cardiovascular research as an important mediator of numerous vascular 
diseases. Initial reports revealed ET-1 to mediate both vasoconstriction and vasodilatation 
of vascular smooth muscle, with the action depending on the presence of an intact 
endothelium (Hirata, et al., 1993; Sumner, Cannon, Mundin, White, & Watts, 1992). 
Subsequent work has shown that ET-1 is the most potent vasoconstrictive peptide known, 
and is essential for the control of vascular tone in the muscular arteries. 
Although ET-1 is mainly synthesized by ECs under physiological conditions, it 
can be produced by non-ECs. ET-1, Ang II, thrombin, and other growth factors can 
induce the expression of preproET-1 mRNA in cultured VSMCs (Sugo, et al., 2001; 
Tchekneva, Quertermous, Christman, Lawrence, & Meyrick, 1998). ET-1 can also be 
released from cardiac myocytes (L. L. Yang, et al., 2004) and cardiac myofibroblasts 
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(Ammarguellat, Larouche, & Schiffrin, 2001; C. M. Cheng, et al., 2003; T. H. Cheng, et 
al., 2003; Gray, Long, Kalinyak, Li, & Karliner, 1998; Sakai, et al., 1996), where it 
appears to play a role in both hypertension and post-myocardial infarction 
(Ammarguellat, et al., 2001; Sakai, et al., 1996). Moreover, it has also been reported that 
ET-1 released from cardiac fibroblasts mediates cardiac hypertrophy via the ETA-receptor 
(Gray, et al., 1998).  
Recently, our lab has shown that Ang II stimulation evokes expression of ET-1 in 
adventitial fibroblasts (An, et al., 2006). The nucleotide sequence of the adventitial 
preproET-1 cDNA was identical to that of the endothelial preproET-1 cDNA. 
Importantly, these results demonstrate a potential function of vascular adventitial 
fibroblasts, since released ET-1 can modulate Ang II-induced ECM generation. 
Furthermore, the Ang II-stimulated type I procollagen-α-1 mRNA expression and protein 
synthesis are inhibited by an ETA-receptor inhibitor, suggesting a potentially meaningful 
role for this interaction at the functional level. 
Oxidative stress may also contribute to ET-1 release. Free radical-generated F2-
isoprostane released during oxidative injury results in the release of ET-1 in bovine aortic 
ECs (Yura, et al., 1999). Additionally, H2O2 increases ET-1 expression in human 
mesangial cells (Hughes, Stricklett, Padilla, & Kohan, 1996), coronary VSMCs (Kaehler, 
et al., 2002; Kahler, et al., 2001), aortic VSMCs (Ruef, Moser, Kubler, & Bode, 2001), 
and umbilical vein ECs (Kaehler, et al., 2002; Kahler, et al., 2000). Consistent with the 
above findings, expression of ET-1 in adventitial fibroblasts is also mediated by .O2- (An, 
et al., 2007). First, .O2- generation in Ang II-treated cells increased concomitantly with 
that of ET-1 synthesis. Second, pharmacological scavengers of .O2- or overexpression of 
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SOD1 have been shown to decrease Ang II-induced ET-1 release. Third, the Ang II-
induced ET-1 expression and .O2- levels were decreased in cells isolated from gp91phox-
null mice, suggesting that gp91phox and its derived .O2- plays an important role in 
mediating ET-1 release from adventitial fibroblasts. Nevertheless, this data also suggests 
that there are mechanisms other than gp91phox-containing NADPH oxidase mediating the 
effect. 
The mechanisms of oxidative stress regulating ET-1 production are still unclear. 
Kahler et al. (2000) reported that oxidative stress increases ET-1 release by activation of 
a promoter for the ET-1 gene. Oxidative stress could activate nuclear factor-kappa B 
(NF-κB) (Geng, Rong, & Lau, 1997), which may stimulate preproET-1 gene expression 
(Bierhaus, et al., 1997). Oxidative stress stimulates the generation of transforming growth 
factor-β (TGF-β) in glomerular cells (Montero, et al., 2000), which could markedly 
enhance ET-1 expression in both rat VSMCs and ECs (Sugo, et al., 2001). Both ROS and 
the Ras-Raf-ERK pathway are required for either Ang II-induced or ET-1-induced ET-1 
gene expression in rat cardiac fibroblasts (C. M. Cheng, et al., 2003) . Antioxidants 
suppress ET-1-induced ET-1 gene expression (C. M. Cheng, et al., 2003), which is 
consistent with the data obtained in the present study. Inhibition of ERK prevents the 
transcription of the ET-1 gene (C. M. Cheng, et al., 2003). Likewise, dominant-negative 
mutants of Ras, Raf, and MEK1 also decrease ET-1 transcription (Cheng, et al., 2001). 
Meanwhile, the effect of NO on ET-1 expression was reported controversially. 
Previously, it was found that inhibition of NO can increase ET-1 production (Hinson, 
Kapas, & Cameron, 1996); however Kahler et al. (2000) reported that the level of NOS 
III mRNA remained unchanged under oxidative stress, and L-NAME did not 
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significantly alter ET-1 promoter activity. 
Consistent with the findings in ET-1 expression, Ang II-induced procollagen-α-I 
expression was inhibited by .O2- scavengers and NADPH oxidase inhibitors (An, et al., 
2007). Moreover, Ang II-induced procollagen-α-I levels were decreased in cells 
overexpressing SOD1 (An, et al., 2007). Our data agree with the findings reported by 
other investigators that .O2- serves to regulate collagen metabolism in cardiac fibroblasts 
through the activation of MMPs (Siwik, Pagano, & Colucci, 2001). Hence, Ang II-
induced oxidative stress regulates ET-1 release, which in turn mediates collagen synthesis 
in adventitial fibroblasts. These findings have important implications for disease states 
associated with remodelling of the vasculature. Rocnik et al. (1998) reported that vascular 
injury can induce a sequence of events in the adventitia that includes the deposition of 
newly synthesized collagens, which in turn is a key factor for VSMC migration. 
Moreover, collagen accumulation contributes to vascular stiffness and changes in 
vascular compliance. Therefore, these findings reveal the mechanism that contributes to 
ET-1 release and collagen deposition in the overall remodelling of the arterial wall in 
various pathological conditions and vascular aging. 
 
1.3.4: ET Receptors 
 
1.3.4.1: ETA 
 The ETA receptor was initially shown to mediate vasoconstriction in the 
vasculature, both in endothelium-intact and endothelium-denuded arteries (Sumner, et al., 
1992; Taddei & Vanhoutte, 1993). The ETA receptor is expressed in both ECs and 
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VSMCs, and may mediate vasoconstriction by acting at each of these sites (Taddei & 
Vanhoutte, 1993). Our lab has also recently shown that the ETA receptor is expressed in 
cultured mouse aortic adventitial fibroblasts (An, et al., 2006), a finding which has been 
confirmed in a tissue-engineered blood vessel model (Laflamme, et al., 2006). In this 
tissue-engineered model, it was also shown that the ETA receptor mediated contractile 
responses in the adventitia-only constructs (Laflamme, et al., 2006).  
 Beyond the well documented vasoactive properties of the ETA receptor in the 
vasculature, the ETA receptor may also mediate numerous growth and proliferatory 
responses. In the long-term, ETA receptor antagonism reduces blood pressure, and 
attenuates vascular remodelling in hypertensive rats (Park & Schiffrin, 2001). In the 
heart, chronic ET-1 signalling through the ETA receptor mediates cardiac fibrosis through 
collagen deposition (Ammarguellat, et al., 2001). Similarly, we have shown attenuated 
collagen production by adventitial fibroblasts after ETA receptor blockade (An, et al., 
2006). Furthermore, we and others have demonstrated an activation of ROS-producing 
pathways, especially the NADPH oxidase pathway, with ET-1 signalling through the ETA 
receptor (An, et al., 2007; K. J. Dammanahalli & Z. Sun, 2008; Laplante, Wu, Moreau, & 
de Champlain, 2005; Zeng, Zhou, Yao, O'Rourke, & Sun, 2008). These pathways 
commonly manifest in disease states, and often regulate growth and proliferation. 
 The ETA receptor is also strongly implicated in disease processes such as 
atherosclerosis and hypertension. After balloon injury of the rat carotid artery, it was 
shown that the ETA receptor is up-regulated in the intimal and medial layers, suggesting a 
role for the ETA receptor in injury-induced cell proliferation (Viswanathan, De Oliveira, 
Johren, & Saavedra, 1997). Furthermore, ETA receptor blockade resulted in a modulation 
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of EC adhesion molecule content, thus altering endothelial cell-leukocyte interactions, a 
hallmark of vascular inflammatory diseases (Callera, et al., 2004). Additionally, ETA 
signalling resulted in decreased expression of eNOS, which further exacerbated a model 
of pulmonary hypertension (Wedgwood & Black, 2005). Thus, in experimental models of 
cardiovascular disease, ETA receptor blockade is generally effective in ameliorating the 
syndrome. 
 
1.3.4.2: ETB 
 The ETB receptor first gained attention for mediating vasodilatory responses when 
stimulated on ECs (Hirata, et al., 1993), but may mediate vasoconstrictive responses 
when stimulated on VSMCs (Sumner, et al., 1992). The ETB receptor has since been 
classified as two distinct receptors which arise from alternative splicing of the ETB 
receptor gene. By convention, the ETB receptor mediating vasodilatation is termed ETB1, 
while the ETB receptor mediating vasoconstriction is termed ETB2 (Shyamala, Moulthrop, 
Stratton-Thomas, & Tekamp-Olson, 1994). The ETB receptor displays no preference for 
either ET-1, ET-2 or ET-3, although the ETA receptor shows significantly higher affinity 
for ET-1 and ET-2 over ET-3 (Sakurai, Yanagisawa, & Masaki, 1992; Sakurai, et al., 
1990). Generally, the ETB receptor has gained notoriety for its ability to mediate 
beneficial effects of ET-1, rather than the detrimental effects that the ETA receptor is 
known to mediate. 
 In the pulmonary vasculature, the ETB receptor has been shown to mediate 
clearance of the ET-1 peptide from the circulation (Dupuis, Goresky, & Fournier, 1996; 
Fukuroda, et al., 1994). It was speculated and later confirmed that the clearance of ET-1 
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mediated by ETB receptors is dependent on the binding of ET-1 to the ETB receptor and 
an internalization and degradation of the ET-1/ETB complex (Dupuis, et al., 1996; 
Fukuroda, et al., 1994; Sanchez, et al., 2002). It has since been demonstrated that the ETB 
receptor regulates the production of ET-1 peptide and mRNA synthesis in vascular cells 
(Farhat, et al., 2008; Ozaki, et al., 1995; Sanchez, et al., 2002). Thus the ETB receptor 
may reduce the detrimental effects of ET-1 in the vasculature partly by clearing it from 
the circulation and down-regulating its production, thus serving as a negative feedback on 
ET-1. 
 Recent work has shown that the ETB receptor may mediate anti-proliferative 
functions in the vasculature. Dammanahalli and Sun (2008) showed that the ETB receptor 
mediates the inhibition of NADPH oxidase in human abdominal aortic ECs. Similarly the 
ETB receptor agonist Sarafotoxin 6c reduces infarct size in the ischemic/reperfused 
myocardium of anaesthetized rats (Crockett, Gray, Kane, & Wainwright, 2004). 
Furthermore, ETB receptors in the endothelium mediate the production of NO, which 
besides its well documented vasodilatory actions, may mediate anti-proliferatory 
responses in the vasculature (Hirata, et al., 1993). Additionally, ETB receptor stimulation 
results in suppression of EC apoptosis (Shichiri, Marumo, & Hirata, 1998). Thus the role 
of the ETB receptor in the mediation of ET-1 signalling in the vasculature is largely 
beneficial, whereas the role of the ETA receptor is not. 
 
1.4: Vascular Aging 
 The process of aging has long been considered a relative mystery in the scientific 
community. The exact reasons and mechanisms by which we age have never been well 
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understood. Numerous theories as to the origins of the aged phenotype have arisen over 
the years. For the purposes of this review, only the biological theories of aging will be 
addressed, since the social theories of aging are not of concern here. 
 
1.4.1: Chronological Aging 
 The simplest concept of aging is the accumulation of changes to an organism over 
time which is commonly referred to as chronological aging. This model of aging also 
serves as the most straightforward to test in an experimental approach since one need not 
assay biomarkers of aging to confirm the animal’s age. This model of aging also takes 
into account the impact of time on the aging phenotype. Numerous specific theories of 
aging propose that the process of aging is a direct result of the accumulation of damage, 
waste, or misrepair (Kulminski, et al., 2007; R. A. Miller, 2009). Each of these theories 
portrays aging as an inevitable, degenerative process; however they do not explain 
individual differences in aged subjects. 
 
1.4.2: Biological Aging 
 The process of aging is often explained by biological changes that occur over 
time. Such a theory of aging is commonly referred to as the biological theory of aging 
and reflects the apparent age of an organism, rather than its actual measurable age. Often 
the concept of biological age is used to explain differences in health and disease from 
similar aged patients, and increasingly is used clinically in determining the efficacy of 
planned treatment options (S. H. Jackson, Weale, & Weale, 2003). In order to accurately 
assess biological age, numerous biomarkers of biological aging have been devised, 
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including oxidative stress (Ungvari, et al., 2008), telomere length (Slijepcevic, 2008), 
AGEs (Safciuc, et al., 2007), and alterations in bone mineral density. 
 Underlying mechanisms proposed for biological aging are wide-ranging and 
diverse. The most common theories involve mitochondrial free radical generation 
(Gruber, Schaffer, & Halliwell, 2008) and accumulative oxidative stress resulting in 
DNA and protein damage (Ungvari, et al., 2008). Consistent with these theories is the 
notion of damage and mis-repair, where a cell manifests aging in terms of incorrect 
repairing of accumulative damage over time. In either case, the resulting phenotype is 
that which is common among the aged population, a general deterioration of structural 
integrity and biological function. 
 The mitochondrial free radical theory of aging proposes that damage caused by 
free radicals generated by mitochondria accumulates over time, leading to the common 
aged phenotype (Gruber, et al., 2008). The main targets of mitochondrial free radicals are 
DNA, both mitochondrial and nuclear. The mitochondrial DNA damage usually leads to 
further mitochondrial dysfunction and an increase in the production of free radicals, 
resulting in a vicious cycle of mitochondrial damage and dysfunction (Gruber, et al., 
2008). The nuclear DNA damage severely limits the cell’s ability to replicate and 
function normally. However, the Mclk1+/- mouse variant displays significantly increased 
mitochondrial oxidative stress and dysfunction, but paradoxically lives significantly 
longer than their wild-type counterparts (Lapointe & Hekimi, 2008). Clearly, the 
mitochondrial free radical theory of aging is one that requires reformulating, and may no 
longer be valid in its current state. 
 Another common theory explaining biological age is telomere length. Telomeres 
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are repeated sequences of DNA at the ends of linear eukaryotic chromosomes which 
shorten with every replication due to the limitations of normal DNA replication enzymes 
(Aubert & Lansdorp, 2008; Lansdorp, 2009). As the organism ages, telomeres shorten 
until they finally erode away, exposing the coding sequences of DNA. At this point, in 
the absence of activated telomerase, the DNA damage can be severe enough as to prevent 
normal replication and the cell dies as a result (Aubert & Lansdorp, 2008; Lansdorp, 
2009). Thus the measurable length of a telomere can accurately portray the effective age 
of an organism. Shortened telomere length has been shown to be associated with 
hypertension (Z. Yang, et al., 2009), coronary artery disease (Ogami, et al., 2004), 
myocardial infarction (Zee, Michaud, Germer, & Ridker, 2009), EC dysfunction and 
atherosclerosis (Minamino & Komuro, 2002). Similarly, long telomere length is 
associated with relatively good health in aged populations (Terry, Nolan, Andersen, 
Perls, & Cawthon, 2008). 
 
1.4.3: Structural and Functional Changes during Aging 
 Vascular aging is a multi-faceted alteration of the vasculature with increasing age. 
Many common vascular diseases such as hypertension and atherosclerosis can be 
attributed, at least in part, to age-related changes in the structure and function of the 
vasculature (Greenwald, 2007; Izzo & Mitchell, 2007). The most common changes seen 
in vascular aging include vascular cell hypertrophy, cell proliferation and apoptosis, 
ECM deposition, and oxidative stress. Each of these factors contributes alone and in 
combination to create an aged phenotype where common chronic vascular diseases 
thrive. Each of these factors has been shown to be directly influenced by the vascular 
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adventitia, although the specific role of the adventitia in aging is yet to be determined. 
 
1.4.3.1: Vascular Hypertrophy 
 Aging has long been associated with structural changes in the vasculature. As the 
vessels age, the elastic compliance of the vessels decreases in a process called 
arteriosclerosis (Izzo & Mitchell, 2007). This decrease in compliance is directly 
influenced by an increase in cell mass of the vessel wall and overall thickening of the 
vessel (Izzo & Mitchell, 2007). The resultant thickened and stiffened vessel loses its 
ability to dampen transient blood pressure peaks caused when the heart ejects blood 
during systole. As a result, blood pressure increases substantially, leading to 
hypertension, which is further associated with additional cardiovascular outcomes, such 
as myocardial infarction and stroke. 
 Briones and colleagues found that aged rat mesenteric arteries demonstrate an 
overall increase in vessel wall thickness, which could be explained by a correlative 
increase in the thickness of the medial smooth muscle layer (Briones, et al., 2007). The 
researchers did not observe a significant increase in the thickness of the adventitial layer, 
however did observe an increase in the number of cells residing in the adventitial layer 
(Briones, et al., 2007). The hypertrophic changes observed in this study were also 
consistent with previous findings in aged rat mesenteric arteries (Adrian, Laurant, & 
Berthelot, 2004; Moreau, et al., 1998). 
 Furthermore, it was found that carotid artery thickness in aging could be wholly 
explained by increases in systolic blood pressure (Tanaka, et al., 2001). However, this 
study did not quantify changes in the adventitia and only determined carotid intima-
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media thickness in assessing vessel wall hypertrophy. Although this study may more 
accurately demonstrate the age-dependent changes in the large elastic conduit arteries, it 
provides no assessment of the adventitia. On the other hand, work done by the same 
group with muscular femoral arteries showed that age-induced thickening is related to 
enhanced sympathetic nervous activity (Dinenno, Jones, Seals, & Tanaka, 2000). Thus, 
the effects of age in inducing hypertrophic changes in the vasculature may relate to the 
action of local mediators on specific locations in the arterial tree, since the elastic carotid 
artery is influenced by factors which do not affect the muscular femoral artery. 
It is well established that many chronic vascular diseases result in pronounced 
vascular cell hypertrophy. Exposure to pressor doses of Ang II for two weeks results in 
salt-sensitive hypertension in rats (Lombardi, et al., 1999). This hypertension was shown 
to be mediated by structural changes in the renal and cardiovascular systems (Lombardi, 
et al., 1999). Further study revealed that chronic Ang II-induced vascular hypertrophy is 
mediated by activation of NADPH oxidase and .O2- production (Wang, Johns, Xu, & 
Cohen, 2002; Wang, et al., 2001). Meanwhile, it was found that Ang II signalling caused 
hypertrophy of cardiac myocytes and that this hypertrophy was mediated by TGF-β and 
ET-1 release by neighbouring cardiac fibroblasts (Gray, et al., 1998). Evidence from our 
own lab has shown that Ang II signalling in cultured aortic adventitial fibroblasts can 
stimulate ET-1 production and release through similar mechanisms (An, et al., 2006; An, 
et al., 2007). Thus, Ang II and ET-1 signalling in the vasculature may play a significant 
role in the age-related changes in vascular structure and function. Furthermore, the 
adventitia may play a role in regulating Ang II and ET-1 signalling through its capacity 
for paracrine signalling in the vessel wall. 
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1.4.3.2: Cell Proliferation and Apoptosis 
 Aging is commonly associated with structural changes of the vessel wall, leading 
to many age-related cardiovascular diseases. One such change in the vasculature with 
aging is cell proliferation and apoptosis. Briones et al found that aging resulted in a 
significant increase in the number of adventitial cells, but resulted in no change in 
VSMCs (Briones, et al., 2007). Interestingly, another study found that senescent human 
fibroblasts express and release vascular endothelial growth factor (VEGF) to a much 
greater degree than pre-senescent fibroblasts (Coppe, Kauser, Campisi, & Beausejour, 
2006). This enhanced release of VEGF contributed to increased tumorigenesis and 
neovascularisation when injected into mice with tumorigenic mouse epithelial cells 
(Coppe, et al., 2006). Similarly, hypoxia induces the emergence of pulmonary artery 
adventitial fibroblasts which lack the anti-replication signal arising from protein kinase 
C-ζ (PKCζ) (Das, Burns, Wilson, Zawada, & Stenmark, 2008). Interestingly, 
antagonizing the effects of TNF-α, a regulator of apoptotic cell death, in aged rats 
decreased the expression of inflammatory markers and exhibited vasculoprotective 
effects (Csiszar, et al., 2007). Thus, cell regulators of proliferation and apoptosis appear 
to play a role in vascular aging phenotypes. 
As with vascular hypertrophy, ET-1 signalling stimulates proliferation of VSMCs 
(Wedgwood, Dettman, & Black, 2001), ECs (Dong, et al., 2005), and adventitial 
fibroblasts (Davie, et al., 2006). Similar proliferatory responses are observed in vascular 
cells upon exposure to extracellular adenosine triphosphate (ATP) (Gerasimovskaya, et 
al., 2002), hypoxia (Das, et al., 2001), F2-isoprostane (Yura, et al., 1999), and platelet-
derived growth factor (PDGF) (Zhan, et al., 2003). Intriguingly, resveratrol, a red-wine 
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polyphenol, can reverse some aspects of vascular aging. Resveratrol can inhibit Ang II-
induced ET-1 gene expression and subsequent cell proliferation in aortic VSMCs (Chao, 
et al., 2005). Additionally, resveratrol can protect ECs from oxidative stress induced 
apoptosis (Ungvari, et al., 2007). 
 
1.4.3.3: Extracellular Matrix Deposition 
Aging is commonly associated with stiffening of the blood vessels, particularly 
the central elastic conduit arteries, which is often due to an excess or dysregulated 
production of ECM proteins (Greenwald, 2007). As an animal ages, the ratio of elastin to 
collagen in the vessel wall drops, the vessel wall stiffens, and is unable to effectively 
dampen the acute blood pressure increases experienced during end systole (Greenwald, 
2007). As a result, the blood pressure rises substantially, and the blood vessels 
compensate by growing thicker. This thickening is often accompanied by an enhanced 
secretion of ECM proteins, primarily collagen, which further stiffens the vessel wall 
(Greenwald, 2007). The resultant remodelled vessel wall may now provide additional 
scaffolding for the migration of fibroblasts (Greiling & Clark, 1997) or VSMCs (Rocnik, 
et al., 1998), which are hallmarks of chronic vascular pathologies such as atherosclerosis. 
The vascular adventitia is chiefly responsible for producing copious ECM 
proteins, particularly collagen and elastin, which maintain structural support of the vessel 
wall (Rey & Pagano, 2002). Although physiological levels of ECM are required for 
normal vascular function, the accumulation of interstitial collagen is associated with 
vascular disease (Intengan & Schiffrin, 2001; Park & Schiffrin, 2001). Excessive 
deposition of ECM proteins, especially collagen, due to pathological conditions such as 
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systemic hypertension, occurs throughout the vessel with initial build-up taking place in 
the adventitial region of arterioles (Nicoletti & Michel, 1999).  Increased production of 
collagen has been demonstrated in adventitial fibroblasts due to stimulation with several 
mitogens, including Ang II (An, et al., 2006) and ET-1 (An, et al., 2007). The increased 
synthesis of procollagen, the precursor of collagen has been observed in cardiac 
fibroblasts by several other substances and forces, including mechanical load (Carver, 
Nagpal, Nachtigal, Borg, & Terracio, 1991), PDGF, basic fibroblast growth factor 
(bFGF), and insulin-like growth factor-1 (IGF-1) (Bishop & Lindahl, 1999). TGF-β also 
serves to up-regulate procollagen production in both cardiac fibroblasts (Bishop & 
Lindahl, 1999) and interstitial fibroblasts of the pulmonary vascular system (Lindahl, et 
al., 2002). Additionally, stimulation with TGF-β, PDGF, or bFGF leads to a decrease in 
collagen degradation (Bishop & Lindahl, 1999). 
The production of another ECM protein, fibronectin, is also proving to be of 
significance as it is involved in many complex cellular functions including tissue repair 
(Briggs, 2005), embryogenesis (Wartiovaara, Leivo, Virtanen, Vaheri, & Graham, 1978), 
and blood clotting (Holland, Harlos, & Blake, 1987).  Indeed, fibronectin produced by 
adventitial fibroblasts is essential for the conversion of fibroblasts to activated 
myofibroblasts (Gabbiani, 2003). The role of fibronectin in cell migration has been 
demonstrated to occur following injury (Greiling & Clark, 1997), with insoluble 
fibronectins bringing together anchoring cells with collagen or proteoglycan substrates 
(A. W. Hahn, Regenass, Kern, Buhler, & Resink, 1993). 
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1.4.3.4: Oxidative Stress  
A state of oxidative stress occurs when the balance of oxidant molecules 
outweighs that of the antioxidants. As a result ROS can overrun the cell, causing severe 
damage to cellular components. Although ROS may have important signalling purposes 
in vascular cells, an overproduction of ROS may commonly occur in numerous vascular 
diseases including atherosclerosis and hypertension. The predominant ROS produced by 
vascular cells include .O2-, H2O2, hydroxyl radical (.OH), and peroxynitrite (OONO-). 
Generally, .O2- is the first ROS produced by vascular cells. All vascular cells can generate 
.O2- (Griendling, Minieri, Ollerenshaw, & Alexander, 1994; Mohazzab, Kaminski, & 
Wolin, 1994; Pagano, et al., 1995), with different cell types containing various .O2- 
generating systems. Xanthine oxidase (White, et al., 1996), NADH oxidase (Munzel, 
Hink, Heitzer, & Meinertz, 1999), and NOS (Munzel, et al., 2000) are present in ECs, 
while NADPH oxidase is present in VSMCs (Griendling, et al., 1994; Ushio-Fukai, 
Zafari, Fukui, Ishizaka, & Griendling, 1996), ECs (Gorlach, et al., 2001)  and adventitial 
fibroblasts (Pagano, Chanock, Siwik, Colucci, & Clark, 1998). Additionally, vascular 
cytochrome P450 (cyt P450) can also generate .O2- and is expressed in virtually all 
vascular cell types (Fleming & Busse, 2001; A. L. Hunter, Bai, Laher, & Granville, 
2005). Figure 3 depicts some of the key ROS generating systems and pathways present in 
the vasculature. 
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Figure 3. Key ROS generating systems and pathways present in the vasculature. The vascular 
adventitia is a potent source of superoxide anion (.O2-), which may combine with nitric oxide (NO) diffused 
from the endothelium or generated locally by inducible nitric oxide synthase (iNOS) to produce the highly 
reactive and destructive peroxynitrite (OONO-). Additionally the tunica media and tunica intima are also 
able to generate .O2-. The vascular .O2- may be dismutated into hydrogen peroxide (H2O2), which may serve 
as a signalling molecule or as a destructive reactive oxygen species. The H2O2 may also be decomposed to 
form hydroxyl radical (-OH), another damaging reactive oxygen species. Abbreviations used: NOX, 
NADPH oxidase; cyt p450, cytochrome p450; XO, xanthine oxidase; eNOS, endothelial nitric oxide 
synthase. 
 
An important application of oxidative stress in the vasculature is the cumulative 
effect of ROS in aging and chronic disease processes. Autopsied patients who had 
suffered from pulmonary hypertension were shown to have greatly thickened adventitial 
layers, due to increased fibroblast proliferation and collagen deposition (Haurani & 
Pagano, 2007). Evidence from studies examining hypoxia (Das, et al., 2001), acute 
vascular injury (G. Li, et al., 2000), shear stress (Garanich, et al., 2007) and ROS 
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generation (Shen, et al., 2006) have shown the capabilities of the adventitia in responding 
to a wide variety of stresses. In each case, the adventitial fibroblasts proliferate, 
differentiate, and migrate, resulting in thickened, stiffened vessels. As a consequence, the 
vessel is not able to dilate as effectively and efficiently, resulting in a common chronic 
state of high blood pressure. The high blood pressure experienced can further exacerbate 
the condition, contributing more shear stress and acute vessel injury, resulting in a 
vicious cycle of further thickening and stiffening. 
Vascular oxidative stress has been reported to mediate vascular hypertrophy. It 
has been reported that H2O2 generated from NADPH oxidase-derived .O2- plays a critical 
role in Ang II-induced hypertrophy of cultured VSMCs by activating growth related 
signalling pathways and growth factors (Ushio-Fukai, Alexander, Akers, & Griendling, 
1998; Ushio-Fukai, et al., 1999). Earlier studies suggested a paracrine effect of ROS on 
medial hypertrophy (Zafari, et al., 1998). Subsequently, it has been reported that Ang II-
induced NADPH oxidase-derived ROS in the adventitia and intima of the aorta is 
concomitant with medial hypertrophy (Wang, et al., 1999). Overexpression of human 
catalase in VSMCs decreased Ang II-induced hypertrophy in vivo (Zafari, et al., 1998), 
and adventitia-specific expression of a peptide that inhibits the ability of gp91phox and 
p47phox to interact, decreases NADPH oxidase activity in the adventitia, and reduces both 
medial ROS levels and medial hypertrophy (Liu, et al., 2004). These data strongly 
support the paracrine effect of adventitial NADPH oxidase-derived ROS, primarily H2O2, 
on vascular hypertrophy. 
Adventitial fibroblasts are involved in arterial repair (G. Li, et al., 2000; Shi, 
Pieniek, et al., 1996) and serve as one of the major sources of vascular ROS production 
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(Ardanaz & Pagano, 2006; Pagano, et al., 1997; Wang, et al., 1999; Wang, et al., 1998). 
Inhibition of adventitial ROS production has been demonstrated to decrease neointimal 
proliferation (Dourron, et al., 2005), hyperplasia (Weaver, et al., 2006), and VSMC 
hypertrophy (Liu, et al., 2004). An intriguing study by Haurani et al. (2008) demonstrated 
that a reduction in NADPH oxidase-derived ROS also reduces adventitial fibroblast 
migration in vitro. Furthermore, adventitial overexpression of extracellular superoxide 
dismutase (ecSOD) significantly reduces neointimal formation in a cuff-injured artery 
model (Ozumi, et al., 2005). These results would strongly suggest that adventitial-derived 
ROS, generated by NADPH oxidase, are a critical mediator of vascular wall remodelling 
and repair following injury. 
Oxidative stress and reactive oxygen species play a major role in the 
differentiation, proliferation and migration of adventitial fibroblasts. Ang II has been 
shown to mediate adventitial fibroblast differentiation to myofibroblasts via NADPH-
oxidase ROS through activation of p38-MAP kinase and JNK pathways (Shen, et al., 
2006). In this response, Ang II mediates an increase in ROS generation by NADPH 
oxidase. The subsequent increase in H2O2 appears to be important in activating the p38-
MAPK and JNK pathways, which mediate gene expression of α-SMA, which serves to 
signal the cell to differentiate to a myofibroblast (Shen, et al., 2006).  
 
1.4.4: Animal Models used in the Study of Aging 
When studying aging of the cardiovascular system, it is useful to devise a 
comparable animal model that can be used to mimic the age-related changes observed in 
humans. The most commonly used animal aging model in cardiovascular research 
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involves common laboratory rat strains such as Fisher 344 (F344) or Brown Norway 
(BN) (Kajstura, et al., 1996; Pacher, et al., 2004). The F344 rat is an inbred strain 
selectively bred by the National Institute of Aging to have smaller body mass, longer 
lifespan and lower spontaneous tumour rate than most other rat strains, making them 
somewhat more comparable to humans in aging studies (Pacher, et al., 2004). These rats 
generally have a maximum lifespan of approximately 3.0 years (36 months). The 
generally accepted standard when using these rats is to use 3-6 month old rats for young 
subjects and 24 month or older rats for old subjects (Anversa, Li, Sonnenblick, & 
Olivetti, 1994; Boluyt, Converso, Hwang, Mikkor, & Russell, 2004; Delp, Evans, & 
Duan, 1998; Pacher, et al., 2004). In comparing to humans, the 3-6 month old rat would 
be comparable in structure and function to a 15-20 year old human, while a 24+ month 
old rat would be comparable to a 60+ year old human (Pacher, et al., 2004). 
Another interesting model of animal aging is the caloric restriction model. It has 
been  found that moderate caloric restriction in aged rats improved markers of normal 
aging such as serum prostaglandins (Choi & Yu, 1998), cerebral blood flow (Lynch, et 
al., 1999), renal damage and failure (Jiang, Liebman, Lucia, Phillips, & Levi, 2005), and 
expression of VCAMs (Zou, et al., 2006). Many aging model rats such as the F344 strain 
are subjected to a calorie restricted diet, which significantly extends lifespan in these 
animals. The precise mechanisms responsible for enhancing lifespan through caloric 
restriction are not fully understood, but could involve an AMPK or SIRT1 pathway since 
treatment with resveratrol has been shown to mimic the effects of caloric restriction 
(Pearson, et al., 2008). 
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2. Rationale, Objectives & Hypotheses 
 
2.1: Summary of Rationale 
 Previous data has clearly demonstrated that the vascular adventitia is a dynamic 
tissue capable of mediating many processes, both in health and disease (An, et al., 2006; 
Dourron, et al., 2005; Garanich, et al., 2007; Kleschyov, et al., 1998; Laflamme, et al., 
2006; Siow & Churchman, 2007; Zhang, Du, Cohen, Chobanian, & Brecher, 1999). The 
vascular adventitia may directly affect and alter the structure and function of the 
vasculature on a whole, and can no longer be considered a passive structural support of 
the vessel wall. The process of vascular aging is commonly associated with structural and 
functional changes in the vessel wall, including hypertrophy (Briones, et al., 2007), cell 
proliferation and apoptosis (Torella, et al., 2004), and ECM deposition (Greenwald, 
2007). Similarly, aging is also associated with a tremendous increase in oxidative stress 
(Csiszar, et al., 2002), which serves to mediate numerous age-related vascular disorders. 
However, the specific role that the adventitia may play in the aging vasculature is still 
unknown. The purpose of this study will be to determine the possible role(s) that the 
adventitia may play in the age related changes of the structure and function of the 
vasculature. 
 
2.2: Objectives & Hypotheses 
Main Hypothesis: The vascular adventitia plays a significant role in the mediation of 
age-related changes in the vasculature. Chief among these changes is the up-regulation of 
key ET system proteins, which presumably would result in enhanced expression of the 
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potent vasoactive and mitogenic peptide ET-1. The enhanced expression of ET-1 would 
then result in vascular wall hypertrophy, increased ECM deposition, and enhanced cell 
proliferation. Additionally, since we have previously demonstrated the production of ET-
1 to be dependent on a ROS signalling pathway (An, et al., 2007), we would expect an 
increase in overall oxidative stress in the vascular wall with advancing age. I hypothesize 
that the vascular adventitia plays a large role in the mediation of each of these processes 
through its propensity for producing ET-1. 
 
2.2.1: Objective 1 
Determine the effect of age on vascular adventitia morphology and thickness. 
1. Determine the changes in cell morphology in the vascular wall and adventitia of 
the rat aorta in different age groups. 
Rationale: Adventitial fibroblasts commonly undergo phenotypic switches to 
myofibroblasts in injury and disease states (Shi-Wen, et al., 2001; Shi, O'Brien, et 
al., 1996; Tomasek, Gabbiani, Hinz, Chaponnier, & Brown, 2002). These changes 
can often be measured through characteristic morphological changes. During 
aging, blood vessels commonly are subjected to numerous injurious stimuli, thus 
requiring the presence of myofibroblasts for remodelling. 
Methods: These changes will be viewed through a haematoxylin and eosin 
staining procedure on each of the 15, 30, 50 and 80 week old rat aorta sections. 
Prediction: It is my hypothesis that the presence of morphologically distinct 
myofibroblasts will be greatly enhanced among aged animals. 
2. Determine the changes in vascular wall and adventitial thickness of the rat aorta 
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with aging. 
Rationale: As has been known for years, blood pressure steadily increases with 
age in most individuals. Along with this increase in blood pressure comes a 
stiffening of the arteries, caused by increased ECM deposition (Izzo & Mitchell, 
2007). Similarly, there may be an associated vascular cell hypertrophy, resulting 
in thicker blood vessels (Briones, et al., 2007). 
Methods: This aspect can be ascertained through haematoxylin and eosin staining 
of the 15, 30, 50 and 80 week old rat aorta sections and measuring the area and 
thickness of the vascular wall and adventitia. 
Prediction: It is my hypothesis that the area and thickness of the adventitia and 
vascular wall will be greater among older animals. 
 
2.2.2: Objective 2 
Determine the effect of age on vascular adventitial cell hypertrophy, proliferation, and 
apoptosis with aging. 
1. Determine the degree of cell hypertrophy in the vascular wall and adventitia of 
the rat aorta in different age groups. 
Rationale: Numerous sources have described an enhanced intima-media 
thickness in the blood vessels of aged subjects (Briones, et al., 2007; Moreau, et 
al., 1998; Tanaka, et al., 2001). Although these studies have not addressed the 
adventitia specifically, one would expect similar growth responses to occur in the 
adventitia. Thus, it would be expected that this enhanced thickening of the vessel 
wall may be partially due to cell hypertrophy both in the adventitia and the rest of 
 45 
 
the vessel wall. 
Methods: Similar to the determination of vascular wall thickness and area 
augmentation with aging, the vascular cell hypertrophy can be determined by the 
ratio of cell mass area to the number of nuclei stained by haematoxylin and eosin 
staining. This will yield a measure of the average size of vascular cells in each of 
the 15, 30, 50 and 80 week old rat aorta sections. 
Prediction: It is my hypothesis that the average size of vascular and adventitial 
cells will increase dramatically with age. 
2. Determine the degree of vascular cell proliferation in the vascular wall and 
adventitia of the rat aorta in different age groups. 
Rationale: Vascular cell proliferation is a common hallmark of many 
cardiovascular diseases (Barandier, et al., 2005; Das, et al., 2001). Since aging is 
associated with increases in numerous cardiovascular diseases, it would be 
reasonable to surmise that vascular cell proliferation (including the adventitia) 
would be enhanced in aging. 
Methods: In order to test this, the expression of Ki67 (a protein expressed only in 
actively proliferating cells) in the vascular adventitia of rat aorta sections isolated 
from 15, 30, 50 and 80 week old animals will be examined by 
immunofluorescence. 
Prediction: It is my hypothesis that Ki67 expression will closely correlate with 
aging. 
3. Determine the degree of cellular apoptosis in the vascular wall and adventitia of 
the rat aorta in different age groups. 
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Rationale: Along with vascular cell proliferation, vascular cell turnover is 
important in the progression of cardiovascular diseases (Desmouliere, Badid, 
Bochaton-Piallat, & Gabbiani, 1997; Intengan & Schiffrin, 2001). One marker for 
cell turnover rate is the amount of apoptotic cells present. 
Methods: Thus, the expression of cleaved Caspase-3 protein, a specific marker of 
apoptosis, will be examined in the vascular adventitia of rat aorta sections isolated 
from 15, 30, 50 and 80 week old animals by immunofluorescence. 
Prediction: It is my hypothesis that the degree of apoptosis will closely correlate 
with aging. 
 
2.2.3: Objective 3 
Determine the effect of age on the expression of the ET system in the vascular adventitia 
in vivo. 
1. Determine the expression of the ET system in the vascular adventitia of rat aorta 
in different age groups. 
Rationale: It has been shown that the ET-1 peptide can cause contraction of a 
tissue engineered adventitial blood vessel (Laflamme, et al., 2006). Additionally, 
we have previously shown that ET-1 is expressed and released by cultured mouse 
aortic adventitial fibroblasts (An, et al., 2006), however a functional ET system 
has yet to be demonstrated in the adventitia in vivo. The aorta serves as an ideal 
location for examining changes in the adventitia since the aorta yields the largest 
amount of adventitial cell mass of any vessel (Greenwald, 2007). Thus, changes 
in the adventitia during aging will be most easily detected in the aorta. 
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Methods: In order to accomplish this objective, aorta sections isolated from 15, 
30, 50 and 80 week old animals will be examined by immunofluorescence. 
Prediction: It is my hypothesis that the ET system proteins are all present in the 
aortic adventitia. 
2. Determine the expression of the ET system in the vascular adventitia of rat 
mesenteric arteries in different age groups. 
Rationale: Although the aorta serves as a great source of adventitial cell mass, 
the smaller muscular arteries are considered to be more important in mediating 
systemic hypertension (Schiffrin, 2003). Additionally, there is some concern that 
the cellular phenotypes observed in the aorta are not consistent with those 
observed in other vascular beds. 
Methods: Thus, the expression of the ET system in mesenteric artery sections 
isolated from 15, 30, 50 and 80 week old animals will be examined by 
immunofluorescence. 
Prediction: It is my hypothesis that the ET system proteins are all expressed in 
the mesenteric artery adventitia. 
3. Determine the expression of the ET system in the vascular adventitia of rat 
pudendal arteries in different age groups. 
Rationale: Further to the above objective, the pudendal artery represents a 
smaller vessel than the mesenteric arteries, and thus may better approximate the 
biology of small resistance vessels (Intengan & Schiffrin, 2000). By examining 
these vessels, we can gain a better understanding of regional differences in 
vascular adventitia biology. 
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Methods: The expression of the ET system in pudendal artery sections isolated 
from 15, 30, 50 and 80 week old animals will be examined by 
immunofluorescence. 
Prediction: It is my hypothesis that the ET system proteins are all expressed in 
the pudendal artery adventitia. 
 
2.2.4: Objective 4 
Determine the downstream intracellular effects of ET-1 in the adventitia in different age 
groups in regards to ROS production, ECM deposition, and myofibroblast induction. 
1. Determine the accumulated effects of ROS production in the vascular adventitia 
of the rat aorta in different age groups. 
Rationale: We have previously shown that the production and release of ET-1 in 
cultured mouse aortic adventitial fibroblasts follows an NADPH oxidase/.O2--
dependent pathway (An, et al., 2007). Additionally, ROS production in aging is 
tremendously important, mediating vascular hypertrophy (Liu, et al., 2004), cell 
migration (Haurani, et al., 2008), and injury repair (Shi, O'Brien, et al., 1996). 
With the capability to produce copious ROS, the adventitia is particularly 
important in aging for its ability to mediate each of these effects. 
Methods: As such, we may be able to detect the intracellular marker of this 
increased .O2- production, namely 3-nitrotyrosine. Thus, the expression of 3-
nitrotyrosine in the vascular adventitia of rat aorta sections isolated from 15, 30, 
50 and 80 week old animals will be examined by immunofluorescence. 
Prediction: It is my hypothesis that the expression of 3-nitrotyrosine will 
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correlate closely to the expression of the ET system in these sections. 
2. Determine the ECM deposition in the vascular adventitia of the rat aorta in 
different age groups. 
Rationale: The process of vascular aging is strongly influenced by ECM 
deposition, with matrix proteins serving as scaffolding for cell migration(Greiling 
& Clark, 1997; Rocnik, et al., 1998), as well as stiffening the vessel wall 
(Greenwald, 2007). We have additionally previously shown that ET-1 stimulation 
in cultured mouse aortic adventitial fibroblasts results in the synthesis of collagen 
type I protein, a major component of the vascular ECM (An, et al., 2007). 
Fibronectin is also a major component of the vascular ECM and has been shown 
to be an important mediator of fibroblast wound repair (Greiling & Clark, 1997; 
A. W. Hahn, et al., 1993). 
Methods: Thus, the expression of fibronectin and collagen type I in the vascular 
adventitia of rat aorta sections isolated from 15, 30, 50 and 80 week old animals 
will be examined by immnuofluorescence. 
Prediction: It is my hypothesis that the expression of fibronectin and collagen 
will also closely correlate to the expression of the ET system in these sections. 
3. Determine the degree of myofibroblast induction in the vascular adventitia of the 
rat aorta in different age groups. 
Rationale: Along with ET-1 expression, ROS production and ECM deposition, it 
has been hypothesized that myofibroblasts are important in mediating 
cardiovascular diseases common among aged populations (Xu, Ji, Li, Chen, & 
Hu, 2007). Myofibroblasts are often involved in injury repair processes, and their 
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presence may result in enhanced vascular stiffness (Gabbiani, 2003). 
Methods: To determine their presence in the vasculature, the expression of α-
SMA (a marker of myofibroblasts) in the vascular adventitia of rat aorta sections 
isolated from 15, 30, 50 and 80 week old animals will be examined by 
immunofluorescence. 
Prediction: It is my hypothesis that the degree of myofibroblast induction will 
correlate to the expression of the ET system in these sections. 
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3: Methodology 
 
3.1: Animals and Tissue Preparation 
 The animal and tissue preparation procedures described below were performed by 
the lab of Dr. Michael A. Adams at Queen’s University, Kingston, Ontario, Canada. All 
animal protocols were approved and conducted according to the recommendations from 
the Research Sub-Committee of Queen’s University on Animal Care and Use and the 
Canadian Council on Animal Care. Male Sprague-Dawley rats were obtained from 
Charles River Laboratories (Toronto, ON). Sprague-Dawley rats were chosen over an 
aging strain such as the F344 strain to provide a more natural aging process, which would 
be unaltered by selective breeding or caloric restriction. Rats were housed individually at 
a temperature of 22-24ºC with a 12hr light/dark cycle. Rats were provided with regular 
rodent chow (LabDiet® 5001, Ren’s Feed and Supply Ltd., Oakville, ON) and tap water 
ad libitum. Blood pressure measurements were recorded through the use of implanted 
radio-telemetry units. At 15, 30, 50, and 80 weeks, animals were anesthetised with 
sodium pentobarbital (65mg/kg, intraperitoneally) followed by intravenous doses of the 
ganglionic blocker hexamethonium and heparin (30mg/kg and 1000 units/kg, 
respectively) to allow for perfusion under maximally relaxed conditions. After the heart 
was excised, the animals were perfused at 70mmHg through the thoracic aorta with saline 
(0.9% NaCl) containing the vasodilator sodium nitroprusside (300mg/L) to facilitate 
flushing out the blood. The animals were then perfusion fixed with 4% paraformaldehyde 
in phosphate buffered saline (137 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 2 mM 
KH2PO4, pH 7.4; PBS). Thoracic aortas, mesenteric arteries, and pudendal arteries were 
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excised, cleaned of extraneous connective tissue and perivascular fat, and stored in 
fixative overnight. These vessels were chosen for analysis for their relative ease of 
isolation as well as providing a representation of elastic conduit arteries (aorta), muscular 
arteries (mesenteric), and small resistance vessels (pudendal). In addition, these vessels 
also provide an estimation of regional differences in the vasculature since each is isolated 
from a separate and distinct region of the body. Vessels were then processed routinely for 
paraffin embedding (1 hr each in graded ethanols [70% x2, 95% x2, 100% x3], xylene 
x2, paraffin x3). Vessels were cut into 5μm sections and placed on glass slides.  
 
3.2: Hematoxylin & Eosin Staining 
 Paraffin embedded tissues were de-waxed in 2-5 minute washes in xylene and 
rehydrated in graded ethanols (2x1 min in 100%, 2x1 min in 95%). Samples were fixed 
in formalin (Sigma) for 5 minutes at room temperature and then rinsed in PBS. Slides 
were stained in hematoxylin (Sigma) for 5 minutes, rinsed in tap water, stained in eosin 
(Sigma) for 5 minutes, and rinsed again in tap water. Samples were dehydrated in an 
ethanol gradient, and mounted with Permount Mounting Medium (Fisher) and a 
coverslip. The mounting medium was allowed to cure for approximately 24 hours before 
analysis, after which point slides were stored at room temperature. Slides were viewed 
under a Nikon light microscope and photomicrographs were taken under the 40X 
objective lens. Images were analyzed for structural and morphological measurements 
using ImageJ software (NIH). 
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3.3: Immunofluorescence Staining 
 Paraffin embedded tissues were de-waxed and rehydrated as described above. 
Sections were then fixed for 15 minutes in acetone/methanol (50/50 vol/vol) at 4ºC. After 
rinsing in PBS twice for 5 minutes each, sections were permeabilized in 0.1% Triton X-
100 (Sigma) in PBS for 5 min at room temperature. Sections were further rinsed in PBS 
twice for 5 minutes each, and blocked in 10% donkey serum (Sigma) in PBS for 1 hour at 
room temperature. Samples were incubated in 1° antibodies at 1:100 dilution overnight at 
4C in 1% donkey serum in PBS. Samples were rinsed in PBS 3 times for 5 minutes each 
and incubated with the 2° antibodies at 1:400 dilution in PBS for 1 hour at room 
temperature, while being maintained in the dark until analysis. Samples were then rinsed 
in PBS 3 times for 5 minutes each and mounted with a cover slip using Prolong Gold 
antifade reagent with DAPI (Invitrogen). The mounting medium was allowed to cure at 
room temperature for approximately 24 hours before analysis, after which point samples 
were stored at 4ºC. Slides were viewed under a Nikon fluorescent microscope, and 
photomicrographs were taken with a 40X objective lens at 4 representative areas per 
section. Images were analyzed for the area and intensity of staining, as well as for 
structural and morphological measurements using ImageJ software (NIH). 
 
3.4 Image Analysis and Quantification 
 Images used for structural and morphological measurements were examined using 
ImageJ software (NIH). The thickness of the vessel wall was determined by measuring 
the distance from the external edge of the lumen to the external edge of the adventitia in a 
direction perpendicular to the vessel wall. This measurement was performed in 
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quadruplicate for each quadrant of the vessel wall and then averaged. The thickness of 
the adventitia was determined by measuring the distance from the external elastic lamina 
to the external edge of the adventitia along the same line used to measure the vessel wall. 
Similarly this measurement was performed in quadruplicate for each quadrant of the 
vessel wall and then averaged. The thickness of the medial layer was determined by 
subtracting each adventitia thickness measurement from the corresponding vessel wall 
thickness measurement which were determined as described above. As with the previous 
measurements, the thickness of the medial layer was measured in quadruplicate for each 
quadrant of the vessel wall and then averaged. Since vessels were not uniformly patent 
for all samples, direct measurement of lumen diameter was not possible. Thus, the lumen 
border of each vessel was traced and measured to determine the lumen circumference 
which was then divided by pi to yield lumen diameter. This measurement was performed 
in quadruplicate for each vessel, and then averaged. 
 Images used for quantifying immunofluorescence staining were analyzed by 
ImageJ software (NIH). Immunofluorescence photomicrographs consisted of a stacked 
three channel RGB image, comprising the DAPI (blue), FITC (green), and TRITC (red) 
channels. To determine immunofluorescent staining in the adventitial layer, the entire 
area comprising the adventitia was highlighted using a tracing tool. The image was then 
broken into individual grayscale images, with one image corresponding to each of the 
DAPI, FITC, and TRITC channels. The individual grayscale images were then 
thresholded to identify positive staining. Each image was then measured for the total area 
of positive staining in the highlighted region, and in the case of DAPI staining, the 
number of individual objects (nuclei) were counted. The same procedure was repeated to 
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determine staining in the medial layer after highlighting the medial layer. Total area 
measurements were also taken for the adventitia and media, regardless of positive 
staining. The positive staining measurements were then divided by the total area 
measurements for their corresponding wall layer to yield a measure of positive 
immunofluorescent staining expressed as a percentage of the total layer area. The total 
area measurements were also used to calculate cell size in each sample by dividing the 
total area measurement by the total number of nuclei present in the corresponding wall 
layer. The method for analyzing immunofluorescent images is shown below in Figure 4. 
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Figure 4. Method for analyzing immunofluorescent images. Immunofluorescence photomicrographs 
consisted of a stacked three channel RGB image, comprising the DAPI (blue), FITC (green), and TRITC 
(red) channels (A). To determine immunofluorescent staining in the adventitial layer, the entire area 
comprising the adventitia was highlighted using a tracing tool (B). The image was then broken into 
individual grayscale images, with one image corresponding to each of the DAPI, FITC, and TRITC 
channels (C – only TRITC channel shown). The individual grayscale images were then thresholded to 
identify positive staining, denoted in red (D). Each image was then measured for the total area of positive 
staining in the highlighted region. The process is repeated for the medial layer. 
 
3.5: Antibodies and Chemicals Used 
 Primary antibodies used were goat collagen type I polyclonal antibody (Santa 
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Cruz sc8784), rabbit ETA polyclonal antibody (Chemicon International AB32860), rabbit 
ETB polyclonal antibody (Chemicon International AB3284), rabbit α-SMA polyclonal 
antibody (Abcam ab5694) rabbit fibronectin polyclonal antibody (Abcam ab299), goat 
ECE-1 polyclonal antibody (Santa Cruz sc27557), goat laminin polyclonal antibody 
(Santa Cruz sc16582), rabbit ET-1 polyclonal antibody (Abbiotec 250633), rabbit Ki67 
polyclonal antibody (Abcam ab66155), rabbit 3-nitrotyrosine polyclonal antibody 
(Invitrogen A21285), rabbit von Willebrand Factor polyclonal antibody (Abcam ab6994), 
rabbit cleaved Caspase-3 polyclonal antibody (Cell Signalling 9661S). Secondary 
antibodies used were donkey anti-rabbit Alexa Fluor 488 (Invitrogen A21206) and 
donkey anti-goat Alexa Fluor 546 (Invitrogen A11056). Mounting medium was ProLong 
Gold antifade with DAPI (Invitrogen P36931) for immunofluorescence and Permount 
Mounting Medium (Fisher SP15-100) for haematoxylin and eosin staining. Other 
reagents used for tissue analysis were Donkey serum (Sigma D9663), Triton X-100 
(Sigma T9284) p-Xylene (Sigma 95682), Acetone (Sigma 534064), Methanol (Sigma 
M3641) Formalin (Sigma 11-0705), Haematoxylin (Sigma H3136), Eosin Y (Sigma 
E4009). 
 
3.6: Statistics 
 Data are expressed as mean ± SEM. Graphic and statistical analyses were 
performed using GraphPad Prism 5.0 software. Analysis of protein expression levels, 
vessel measurements, and cell size in samples with more than two groups were performed 
using one-way ANOVA with Tukey’s post hoc test. Analysis of protein expression 
levels, vessel measurements, and cell size in samples with two groups were performed 
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using Student’s t-test. Differences were accepted as statistically significant at a p-value 
<0.05. 
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4: Results 
 
4.1 Vascular Adventitia Morphology and Vessel Wall Thickness 
 
4.1.1 Vascular Adventitia Morphology 
 As evidenced from histological examination of the tissues, the vascular wall 
changes dramatically with aging. The 15 week old aorta sections display a clean and 
organized vessel wall, with clearly demarcated elastic laminas between layers of medial 
VSMCs. The adventitial region of the 15 week old aortas is also relatively small and 
compact compared to its older counterparts. Overt morphological changes are apparent as 
early as 30 weeks of age, with aorta sections displaying disorganized elastic laminas, 
larger VSMCs, and an expansion of the adventitia. As the aorta increases in age, the 
degree of cellular disorganization increases as well, and the 80 week old aorta sections 
display a vastly different morphology to their 15 week old counterparts. A similar 
relationship is found in the mesenteric arteries, with the 15 week old controls displaying a 
relatively small and organized vessel wall structure compared to their older counterparts. 
At 80 weeks of age, the mesenteric artery wall appears vastly different from that of the 15 
week old controls. This relationship is most apparent in the pudendal artery sections, with 
the 15 week old controls displaying a similarly clean and organized vessel wall compared 
to its 80 week old counterparts. 
 In addition, the vascular adventitia of each vessel type is most likely comprised 
primarily of fibroblasts, since cell marker analysis displayed minimal expression of von 
Willebrand Factor (ECs; Figure A-2), CD4 (macrophages; Figure A-3), c-kit (stem cells; 
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Figure A-4), and α-SMA (VSMCs; Figures 43 & 45) in the adventitia.  
 
4.1.2 Vessel Wall Morphometry 
 
4.1.2.1 Aortic Wall Morphometry 
 The key morphometric measurements of the aortic wall are presented below in 
Table 1. As expected, the thickness of the aortic wall increased dramatically with 
increasing age, with the 80 week old aortas displaying approximately a 75% increase 
over the 15 week old aortas (Table 1). Both the medial and adventitial layers increased in 
thickness, first reaching significance at 30 and 50 weeks for the media and adventitia, 
respectively. The increase in aortic wall thickness progressed consistently thereafter until 
80 weeks of age. At each time point, the medial layer was significantly thicker than its 
corresponding adventitia (Table 1). Aortic cross sectional area (CSA) showed a similar 
relationship, with total wall CSA increasing progressively with increasing age, and 
medial CSA always remaining more substantial than its corresponding adventitia CSA 
(Table 1). 
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Table 1. Morphometric measurements of the aortic wall. 
  
Measurement 15 wks 30 wks 50 wks 80 wks 
Wall Thickness (μm) 224.6 ± 6.3c,d 253.6 ± 5.6a,d 258.7 ± 5.7a,d 342.6 ± 4.4a.b.c 
Media Thickness (μm) 133.0 ± 2.6b,c,d,e 157.4 ± 2.7a,d,e 151.8 ± 1.9a,d,e 223.1 ± 2.5a,b,c,e 
Adventitia Thickness (μm) 91.5 ± 4.7c,d 96.2 ± 3.8d 106.8 ± 4.6a 119.4 ± 2.9a,b 
Adventitia:Media Ratio (%) 65.6 ± 3.6 57.2 ± 3.4 66.8 ± 3.6 54.1 ± 1.9 
Wall CSA (x 103 μm2) 1044.1 ± 64.5b,c,d 1397.4 ± 88.7a,d 1532.3 ± 71.4a,d 2198.7 ± 31.4a,b,c 
Media CSA (x 103 μm2) 593.0 ± 28.6b,c,d,e 834.7 ± 35.9a,d,e 866.4 ± 30.2a,d,e 1341.7 ± 23.0a,b,c,e 
Adventitia CSA (x 103 μm2) 451.0 ± 39.9c,d 562.7 ± 55.0d 665.8 ± 48.9a,d 857.0 ± 25.0a,b,c 
Lumen Diameter (μm) 1347.1 ± 14.3b,c,d 1526.7 ± 13.6a,c,d 1611.7 ± 21.6a,b 1657.0 ± 18.7a,b 
Wall:Lumen Ratio (%) 15.7 ± 2.2d 16.2 ± 2.5d 16.1 ± 1.8d 21.1 ± 2.0a,b,c 
  
Mean ± SEM; ap<0.05 vs. 15 wks; bp<0.05 vs. 30 wks; cp<0.05 vs. 50 wks; dp<0.05 vs. 80 wks, ep<0.05 vs. corresponding adventitia 
 
Despite the media consistently being thicker than its corresponding adventitia, the 
increase in adventitial thickness is paralleled by the increase in medial thickness with age 
as evidenced by the adventitia to media thickness ratio (Table 1). From 15 weeks to 80 
weeks there was no observed change in adventitia to media thickness ratio, suggesting the 
adventitia is growing at a similar rate to the media with increasing age.  
From 15 to 50 weeks of age, the growth in the aortic wall thickness occurred at a 
pace that matched the advancing growth in lumen diameter (Table 1). However, at 80 
weeks of age, aortic wall thickness grew beyond the pace set by lumen diameter (Table 
1). 
 
4.1.2.2 Mesenteric Artery Wall Morphometry 
 The key morphometric measurements of the mesenteric artery wall are presented 
below in Table 2. The mesenteric artery wall also expanded in thickness with increasing 
 62 
 
age, however less consistently than in the aorta. Again, both the medial and adventitial 
layers of the vessel wall thickened with age, reaching significance at 30 and 80 weeks, 
respectively, when compared to the 15 week old controls (Table 2). Unlike the aortic 
wall, at all time points the mesenteric artery adventitial layer remained significantly 
thicker than its corresponding medial layer (Table 2). Similarly, total wall CSA increased 
from 15 to 30 weeks, before decreasing non-significantly at 50 weeks then increasing 
again at 80 weeks. At all time points, adventitial CSA was greater than its corresponding 
medial CSA. 
 
Table 2. Morphometric measurements of the mesenteric artery wall. 
  
Measurement 15 wks 30 wks 50 wks 80 wks 
Wall Thickness (μm) 85.9 ± 6.0b,d 115.3 ± 4.1a,c,d 76.3 ± 3.1b,d 139.0 ± 5.4a,b,c 
Media Thickness (μm) 30.4 ± 1.7b,d,e 35.9 ± 0.9a,c,d,e 29.2 ± 0.5b,d,e 67.3 ± 2.2a,b,c,e 
Adventitia Thickness (μm) 55.4 ± 4.1b,d 79.3 ± 3.5a,d 45.9 ± 2.6b,d 79.6 ± 2.9a,c 
Adventitia:Media Ratio (%) 184.8 ± 11.0b,d 224.7 ± 10.1a,c,d 155.5 ± 7.9b,d 120.3 ± 3.5a,b,c 
Wall CSA (x 103 μm2) 101.8 ± 7.2b,c,d 221.4 ± 16.9a,d 193.4 ± 12.9a,d 327.2 ± 24.5a,b,c 
Media CSA (x 103 μm2) 41.2 ± 4.1b,c,d,e 65.7 ± 3.9a,d,e 63.8 ± 3.9a,d,e 137.2 ± 8.2a,b,c,e 
Adventitia CSA (x 103 μm2) 60.6 ± 4.6b,c,d 155.6 ± 15.7a 129.5 ± 11.3a,d 190.0 ± 17.8a,c 
Lumen Diameter (μm) 504.6 ± 21.3c,d 522.3 ± 16.3c,d 635.6 ± 19.7a,b 653.7 ± 19.0a,b 
Wall:Lumen Ratio (%) 11.7 ± 3.3b,d 21.3 ± 4.1a,c 13.5 ± 2.9b,d 20.8 ± 6.2a,c 
  
Mean ± SEM; ap<0.05 vs. 15 wks; bp<0.05 vs. 30 wks; cp<0.05 vs. 50 wks; dp<0.05 vs. 80 wks, ep<0.05 vs. corresponding adventitia 
 
 In the case of the mesenteric arteries, the increase in adventitial wall thickness did 
not match the increase in medial wall thickness with increasing age. Although at 30 
weeks the adventitia to media thickness ratio is actually greater than at 15 weeks, the 
relationship then turns downward with significant decreases between 30 and 50 weeks, as 
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well as between 50 and 80 weeks (Table 2). 
 The mesenteric arteries display a biphasic relationship between age and wall to 
lumen ratio. Both the 30 and 80 week old groups display a wall to lumen ratio that is 
significantly greater than that displayed by both the 15 and 50 week old groups (Table 2). 
 
4.1.2.3 Pudendal Artery Wall Morphometry 
 The key morphometric measurements of the pudendal artery wall are presented 
below in Table 3. Like the aortic and mesenteric samples, the pudendal artery sections 
displayed an increase in overall wall thickness with increasing age. Although the 
adventitial layer displayed no significant change in thickness from 15 to 80 weeks, the 
medial layer thickness more than tripled between 15 and 80 weeks (Table 3). 
Interestingly, the media was significantly thinner than the adventitia at 15 weeks of age, 
but grew to be significantly thicker than the adventitia at 80 weeks of age (Table 3). 
Conversely, the adventitial CSA actually increased from 15 to 80 weeks, although not 
significantly. 
Unsurprisingly, the pudendal artery adventitia to media thickness ratio also 
plummeted between 15 and 80 weeks of age, suggesting a much greater hypertrophy in 
the medial layer as compared to the adventitia (Table 3). Furthermore the pudendal 
arteries displayed a massive increase in wall to lumen ratio between 15 and 80 weeks of 
age (Table 3). 
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Table 3. Morphometric measurements of the pudendal artery wall. 
  
Measurement 15 wks 80 wks 
Wall Thickness (μm) 132.0 ± 10.6 239.9 ± 12.0a 
Media Thickness (μm) 42.1 ± 2.7b 154.0 ± 6.7a,b 
Adventitia Thickness (μm) 89.9 ± 9.1 85.9 ± 7.3 
Adventitia:Media Ratio (%) 220.0 ± 18.5 56.3 ± 4.0a 
Wall CSA (x 103 μm2) 265.1 ± 50.9 521.3 ± 34.2a 
Media CSA (x 103 μm2) 71.1 ± 11.0b 310.6 ± 24.2a,b 
Adventitia CSA (x 103 μm2) 194.0 ± 41.5 210.7 ± 16.9 
Lumen Diameter (μm) 476.1 ± 16.4 525.6 ± 12.2a 
Wall:Lumen Ratio (%) 27.1 ± 3.1 42.1 ± 2.2a 
  
Mean ± SEM; ap<0.05 vs. 15 wks, bp<0.05 vs. corresponding adventitia 
 
 
4.2 Cell Hypertrophy, Proliferation and Apoptosis 
 
4.2.1 Cell Hypertrophy 
 
4.2.1.1 Aortic Cell Hypertrophy 
 The average size of the cells of the aortic adventitia increased substantially with 
age with each of the 30, 50, and 80 week old samples displaying significantly larger 
aortic adventitial cells than their 15 week old counterparts (Figure 5). Similarly, the cells 
of the aortic media also increased with age, following a similar pattern to the cells of the 
adventitia. However, the increase in medial cell size with age was far less dramatic than 
the increase in adventitial cell size. At each time point, the average size of adventitial 
cells was greater than that of their corresponding medial cells (Figure 5). 
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Figure 5. Average cell area in the aortic wall. Cells in the aortic adventitia displayed a great increase in 
size at 30, 50, and 80 weeks compared to 15 weeks (open bars), while medial cells showed a similar 
increase in overall size only at 30, 50 and 80 weeks compared to 15 weeks (filled bars). At each time point, 
the average size of adventitial cells was greater than that of the medial cells. Data are expressed as mean ± 
SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test. *p<0.05 vs. 15wks group, #p<0.05 vs. 
corresponding adventitia; N=10 per group. 
 
4.2.1.2 Mesenteric Artery Cell Hypertrophy 
 The average size of the cells in the mesenteric artery adventitia also increased 
substantially with age, with cells displaying a significant increase in average size at both 
30 and 80 weeks as compared to the 15 week old controls (Figure 6). The mesenteric 
medial cells also grew in average size with increasing age, but far less dramatically than 
in the adventitia. The increase in medial cell size was significant only at 80 weeks of age, 
when compared to the 15 week old controls. As with the aortic cells, at all time points the 
average size of cells in the adventitia was greater than the average size of cells in the 
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media (Figure 6). 
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Figure 6. Average cell area in the mesenteric artery wall. Average cell size increased over time in both 
the adventitia (open bars) and media (filled bars). The average cell size was significantly greater in the 
adventitia at 30 and 80 weeks when compared to the 15 week old controls. Furthermore, the average cell 
size in the media was significantly greater at 80 weeks when compared to all other time points. At all time 
points, the average cell size was greater in the adventitial layer than in the medial layer. Data are expressed 
as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test. *p<0.05 vs. 15wks group, 
#p<0.05 vs. corresponding adventitia; N=8 per group. 
 
4.2.1.3 Pudendal Artery Cell Hypertrophy 
 The average size of the cells in the pudendal artery increased slightly with age, 
significantly in the medial layer, but non-significantly in the adventitial layer (Figure 7). 
At each time point, the average size of cells in the adventitial layer was greater than the 
average size of cells in the medial layer (Figure 7). 
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Figure 7. Average cell area in the pudendal artery wall. Average cell size increased significantly with 
increasing age in the media (filled bars), but remained unchanged in the adventitia (open bars). At each 
time point, the average cell size was greater in the adventitial layer than in the medial layer. Data are 
expressed as mean ± SEM. Data were analyzed by Student’s t-test. *p<0.05 vs. 15wks group, #p<0.05 vs. 
corresponding adventitia; N=5-6 per group. 
 
4.2.2 Ki67 Expression 
 Expression of the Ki67 cell proliferation marker in the aorta was almost entirely 
specific to the adventitial region at all ages (Figure 8). 
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Figure 8. Ki67 protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks (B), 50 
weeks (C) and 80 weeks (D) all expressed Ki67 protein primarily in the adventitial layer. Thoracic aortas 
were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then 
immunostained for Ki67 and detected with a secondary antibody conjugated to Alexa Fluor 546 (red). 
Nuclei were visualized using DAPI (blue). Samples were viewed under a Zeiss fluorescent microscope with 
a 20X objective lens. Scale bars represent 100μm. 
 
 Quantification of Ki67 expression in the aorta revealed that the 30 and 80 week 
old aortas displayed significantly higher Ki67 expression in the adventitial layer 
compared to the 15 week old controls (Figure 9). In contrast, the Ki67 expression in the 
medial layer of the aorta showed a mild steady increase from ages 15 to 80 weeks, 
although not reaching significance. At 30 and 80 weeks of age, the relative expression of 
Ki67 was much greater in the adventitia compared to the media (Figure 9). 
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Figure 9. Quantitative analysis of Ki67 protein expression in the aortic wall. The aortic adventitia 
(open bars) displayed a significantly higher concentration of Ki67 than the medial layer (filled bars) at 30 
and 80 weeks. Additionally, the adventitia displayed significantly greater Ki67 expression at 80 weeks 
when compared to 15 weeks. The aortic medial expression of Ki67 did not change with increasing age. 
Data are expressed as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test.  
*p<0.05 vs. 15wks group, #p<0.05 vs. corresponding adventitia; N=3-4 per group. 
 
4.2.3 Caspase-3 Expression 
 Expression of the apoptotic signal cleaved caspase-3 displayed very little 
localization to the aortic wall in all age groups (Figure 10). 
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Figure 10. Cleaved caspase-3 protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 
weeks (B), 50 weeks (C) and 80 weeks (D) expressed very little caspase-3 protein. Thoracic aortas were 
isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then 
immunostained for cleaved caspase-3 and detected with a secondary antibody conjugated to Alexa Fluor 
546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent 
microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantification of cleaved caspase-3 expression in the aorta revealed very low 
levels of expression throughout the aortic wall, but slightly more expression in the medial 
layer. The difference in expression between the adventitial and medial layers at all time 
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points was not significant (Figure 11). 
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Figure 11. Quantitative analysis of caspase-3 protein expression in the aortic wall. The expression of 
caspase-3 did not change significantly with increasing age in either of the adventitial (open bars) or medial 
(filled bars) layers of the aortic wall. Expression was significantly greater in the medial layer of the 50 
week old group compared to the adventitia, but did not differ in any other age group. Data are expressed as 
mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test. N=4 per group. 
 
4.3 Endothelin system expression 
 
4.3.1 Aorta 
 
4.3.1.1 ET-1 
 The expression of the ET-1 peptide in the aorta was not localized to any layer or 
compartment of the vessel wall, and as such ET-1 was found expressed throughout the 
vessel wall (Figure 12). 
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Figure 12. ET-1 protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks (B), 50 
weeks (C) and 80 weeks (D) all expressed ET-1 peptide throughout the vessel wall. Thoracic aortas were 
isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then 
immunostained for ET-1 and detected with a secondary antibody conjugated to Alexa Fluor 488 (green). 
Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent microscope 
with a 40X objective lens. Scale bars represent 100μm. 
 
 Furthermore, quantitative analysis of ET-1 expression in the aorta revealed that 
expression in the adventitial layer was fairly low at all ages (Figure 13). The medial 
expression of the ET-1 peptide was consistent across all age groups, declining only 
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slightly with age, without reaching significance. At all time points the medial layer 
exhibited significantly greater expression than the adventitia (Figure 13). 
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Figure 13. Quantitative analysis of ET-1 protein expression in the aortic wall. ET-1 protein was 
expressed consistently in the medial layer (filled bars) at all ages, yet showed an inconsistent expression 
pattern in the adventitia (open bars). In the adventitia ET-1 expression was significantly lower in the 30 and 
80 week old groups compared to the 15 week old controls. ET-1 expression was significantly greater in the 
medial layer compared to the adventitial layer at all time points. Data are expressed as mean ± SEM. Data 
were analyzed by ANOVA with a Tukey’s post-hoc test.  *p<0.05 vs. 15wks group, #p<0.05 vs. 
corresponding adventitia; N=4-5 per group. 
 
4.3.1.2 ECE-1 
The expression of ECE-1 in the aorta was localized to a thin band on the 
endothelium (present in some sections), and as a thick swath through the adventitia 
(Figure 14).  
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Figure 14. ECE-1 protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks (B), 50 
weeks (C) and 80 weeks (D) all expressed ECE-1 abundantly in the vascular adventitia. Thoracic aortas 
were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then 
immunostained for ECE-1 and detected with a secondary antibody conjugated to Alexa Fluor 546 (red). 
Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent microscope 
with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantitative analysis of ECE-1 expression in the aorta revealed consistent 
expression across all age groups in both the adventitial and medial layers (Figure 15). 
However, expression of ECE-1 was on the order of 10 to 30-fold greater in the adventitia 
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than in the media at all time points (Figure 15). 
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Figure 15. Quantitative analysis of ECE-1 protein expression in the aortic wall. ECE-1 protein was 
expressed robustly and consistently in the adventitial layer (open bars) at all ages, yet showed minimal 
expression in the media (filled bars). Expression was significantly greater in the adventitia than the media 
at all time points. However, expression did not differ with increasing age in neither the adventitia nor the 
media. Data are expressed as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test.  
#p<0.05 vs. corresponding adventitia; N=6-7 per group. 
 
4.3.1.3 ETA Receptor 
The expression of the ETA receptor in the aorta exhibited a similar pattern to that 
of the ET-1 peptide. Expression was not localized to any layer or compartment, but 
expressed throughout the vessel wall (Figure 16). 
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Figure 16. ETA receptor protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks 
(B), 50 weeks (C), and 80 weeks (D) expressed the ETA receptor throughout the vessel wall.  Thoracic 
aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were 
then immunostained for ETA receptor and detected with a secondary antibody conjugated to Alexa Fluor 
488 (green). Nuclei were visualized using DAPI (blue). Samples were viewed under a Zeiss fluorescent 
microscope with a 20X objective lens. Scale bars represent 100μm. 
 
 A closer quantitative examination of ETA receptor expression in the aorta revealed 
a consistently greater expression in the medial layer, as compared to the adventitia, at all 
time points (Figure 17). Expression of the ETA receptor in the adventitia did not vary 
across the different age groups, but in the media was greater, although not significantly, 
in the 80 week old group as compared to all other time points (Figure 17). 
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Figure 17. Quantitative analysis of ETA receptor protein in the aortic wall. ETA receptor expression did 
not change significantly with age in neither the adventitia (open bars) nor the media (filled bars). However, 
ETA receptor expression was significantly greater in the medial layer as compared to the adventitial layer at 
all time points. Data are expressed as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-
hoc test. #p<0.05 vs. corresponding adventitia; N=5-6 per group. 
 
4.3.1.4 ETB Receptor 
 The expression of the ETB receptor in the aorta followed a similar pattern to that 
of ECE-1 expression, exhibiting a thin band on the endothelium and a thick swath in the 
adventitia (Figure 18). 
 78 
 
 
Figure 18. ETB receptor protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks 
(B), 50 weeks (C), and 80 weeks (D) expressed the ETB receptor abundantly in the adventitia.  Thoracic 
aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were 
then immunostained for ETB receptor and detected with a secondary antibody conjugated to Alexa Fluor 
546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Zeiss fluorescent 
microscope with a 20X objective lens. Scale bars represent 100μm. 
 
 As with ECE-1 expression, the expression of the ETB receptor in the adventitia 
and media was consistent across all age groups. However, the adventitia exhibited 30 to 
80-fold greater ETB receptor protein expression than that of the medial layer (Figure 19). 
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Figure 19. Quantitative analysis of ETB receptor protein expression in the aortic wall. The ETB 
receptor was expressed robustly and consistently in the adventitial layer (open bars), but displayed 
significantly less expression in the medial layer (filled bars) of all age groups. ETB receptor expression did 
not differ in neither the adventitial nor the medial layers with increasing age. Data are expressed as mean ± 
SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test.  #p<0.05 vs. corresponding adventitia; 
N=4-5 per group. 
 
4.3.2 Mesenteric Arteries 
 
4.3.2.1 ET-1 
As with ET-1 expression in the aorta, expression of ET-1 in the mesenteric 
arteries did not appear to localize to any layer, with expression spread throughout the 
vessel wall (Figure 20).  
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Figure 20. ET-1 protein localization in the mesenteric artery wall. Rat mesenteric arteries aged 15 
weeks (A), 30 weeks (B), 50 weeks (C), and 80 weeks (D) displayed ET-1 protein localized throughout the 
mesenteric artery wall, with slightly more in the medial layer. Mesenteric arteries were isolated, formalin 
fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then immunostained for ET-1 and 
detected with a secondary antibody conjugated to Alexa Fluor 488 (green). Nuclei were visualized using 
DAPI (blue). Samples were viewed under a Nikon fluorescent microscope with a 40X objective lens. Scale 
bars represent 100μm. 
 
Quantitative analysis of ET-1 expression in the mesenteric arteries revealed no 
significant changes in expression across time points in either of the adventitial or medial 
layers (Figure 20). With the exception of 15 weeks of age, ET-1 expression in the medial 
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layer was greater than the adventitial layer, reaching significance at 30 weeks of age 
(Figure 21). 
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Figure 21. Quantitative analysis of ET-1 protein expression in the mesenteric artery wall. ET-1 
protein expression did not differ significantly across time points in either the adventitia (open bars) or the 
media (filled bars). However, ET-1 protein expression was significantly greater in the medial layer at 30 
weeks of age as compared to the adventitia. Data are expressed as mean ± SEM. Data were analyzed by 
ANOVA with a Tukey’s post-hoc test. #p<0.05 vs. corresponding adventitia; N=3-4 per group. 
 
4.3.2.2 ECE-1 
 Expression of ECE-1 in the mesenteric arteries followed a similar pattern to that 
of the aorta. Expression was localized to a thin band on the endothelium, as well as a 
thick swath in the adventitia (Figure 22). 
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Figure 22. ECE-1 protein localization in the mesenteric artery wall. Rat mesenteric arteries aged 15 
weeks (A), 30 weeks (B), 50 weeks (C) and 80 weeks (D) all expressed ECE-1 abundantly in the vascular 
adventitia. Mesenteric arteries were isolated, formalin fixed, embedded in paraffin and serially sectioned at 
5μm. Samples were then immunostained for ECE-1 and detected with a secondary antibody conjugated to 
Alexa Fluor 546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon 
fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantification of ECE-1 expression in the mesenteric arteries revealed fairly 
consistent expression levels from 15 to 50 weeks in the adventitial layer, with a sharp 
significant increase at 80 weeks of age (Figure 23). On the other hand, medial expression 
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of ECE-1 remained consistent across all time points. At 15, 30 and 80 weeks of age, 
expression of ECE-1 in the mesenteric artery adventitia was significantly higher than 
expression in the corresponding medial layer (Figure 23). 
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Figure 23. Quantitative analysis of ECE-1 protein expression in the mesenteric artery wall. ECE-1 
protein expression did not differ significantly across time points in the medial layer (filled bars). However, 
ECE-1 protein expression was significantly greater in at 80 weeks of age as compared to all other time 
points in the adventitia (open bars). At 15, 30, and 80 weeks of age, ECE-1 expression was significantly 
greater in the adventitia as compared to the medial layer. Data are expressed as mean ± SEM. Data were 
analyzed by ANOVA with a Tukey’s post-hoc test.  *p<0.05 vs. 15wks group, #p<0.05 vs. corresponding 
adventitia; N=6-7 per group. 
 
4.3.2.3 ETA Receptor 
 As with the aorta, expression of the ETA receptor did not appear to localize to any 
specific layer (Figure 24). 
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Figure 24. ETA receptor protein localization in the mesenteric artery wall. Rat mesenteric arteries aged 
15 weeks (A), 30 weeks (B), 50 weeks (C), and 80 weeks (D) displayed ETA receptor protein localized 
throughout the mesenteric artery wall. Mesenteric arteries were isolated, formalin fixed, embedded in 
paraffin and serially sectioned at 5μm. Samples were then immunostained for ETA receptor and detected 
with a secondary antibody conjugated to Alexa Fluor 488 (green). Nuclei were visualized using DAPI 
(blue). Samples were viewed under a Nikon fluorescent microscope with a 40X objective lens. Scale bars 
represent 100μm. 
 
 Further quantitative analysis of ETA receptor expression in the mesenteric arteries 
revealed no significant changes in expression across time points in the adventitial layer 
(Figure 25). In the media, expression of the ETA receptor was significantly higher at 80 
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weeks of age compared to the 15 week old controls (Figure 25). Additionally, no 
significant differences were observed between the adventitia and media at all time points 
(Figure 25). 
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Figure 25. Quantitative analysis of ETA receptor protein expression in the mesenteric artery wall. 
Expression of the ETA receptor did not differ significantly across time points in the adventitia (open bars) 
but was significantly higher at 80 weeks as compared to 15 weeks in the media (filled bars). Additionally, 
no difference in expression was observed between the adventitial and medial layers at any time point. Data 
are expressed as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test. *p<0.05 vs. 
corresponding adventitia; N=5 per group. 
 
4.3.2.4 ETB Receptor 
 As in the aortic sections, expression of the ETB receptor protein was highly 
localized to the adventitial layer of the mesenteric arteries, along with a thin band in the 
endothelium (Figure 26). 
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Figure 26. ETB receptor protein localization in the mesenteric artery wall. Rat mesenteric arteries aged 
15 weeks (A), 30 weeks (B), 50 weeks (C), and 80 weeks (D) expressed the ETB receptor abundantly in the 
adventitia.  Mesenteric arteries were isolated, formalin fixed, embedded in paraffin and serially sectioned at 
5μm. Samples were then immunostained for ETB receptor and detected with a secondary antibody 
conjugated to Alexa Fluor 546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed 
under a Nikon fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 A closer quantitative examination of the ETB receptor protein expression in the 
mesenteric arteries revealed a consistent expression level in the adventitia from 15 to 50 
weeks of age, with a large significant increase at 80 weeks of age (Figure 27). ETB 
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receptor protein expression was fairly consistent across time points in the medial layer 
(Figure 27). At all time points, ETB receptor protein expression was significantly higher 
in the adventitia than in the media (Figure 27). 
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Figure 27. Quantitative analysis of ETB receptor protein expression in the mesenteric artery wall. In 
the adventitia (open bars), expression of the ETB receptor was significantly greater at 80 weeks of age 
compared to all other time points. Meanwhile, in the media (filled bars), ETB receptor expression did not 
differ across time points. At all time points, ETB receptor expression was significantly greater in the 
adventitia as compared to the media. Data are expressed as mean ± SEM. Data were analyzed by ANOVA 
with a Tukey’s post-hoc test.  *p<0.05 vs. 15wks group, #p<0.05 vs. corresponding adventitia; N=5 per 
group. 
 
4.3.3 Pudendal Arteries 
 
4.3.3.1 ET-1 
 As with the aortic and mesenteric artery sections, ET-1 expression did not appear 
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to localize to any specific layer in the pudendal arteries (Figure 28). 
 
Figure 28. ET-1 protein localization in the pudendal artery wall. Rat pudendal arteries aged 15 weeks 
(A) and 80 weeks (B) displayed ET-1 protein localized to the entire pudendal artery wall, with a sharp band 
at the endothelium. Pudendal arteries were isolated, formalin fixed, embedded in paraffin and serially 
sectioned at 5μm. Samples were then immunostained for ET-1 and detected with a secondary antibody 
conjugated to Alexa Fluor 488 (green). Nuclei were visualized using DAPI (blue). Samples were viewed 
under a Nikon fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantification of ET-1 expression in the pudendal arteries revealed a sharp drop 
in expression with increasing age in both the adventitial and medial layers (Figure 29). 
Furthermore, the expression of ET-1 did not differ significantly between the adventitia 
and media at either time point (Figure 29). 
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Figure 29. Quantitative analysis of ET-1 protein expression in the pudendal artery wall. ET-1 protein 
expression in the pudendal arteries was greater in the 15 week old group than in the 80 week old group in 
both the adventitia (open bars) and the media (filled bars). Furthermore ET-1 protein expression did not 
differ between the adventitia and media at each time point. Data are expressed as mean ± SEM. Data were 
analyzed by Student’s t-test. *p<0.05 vs. 15wks group; N=4-5 per group. 
 
4.3.3.2 ECE-1 
 Similarly to the aortic and mesenteric artery sections, the pudendal arteries 
displayed a high degree of localization of ECE-1 protein in the adventitial layer, with 
much less in the medial layer (Figure 30). 
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Figure 30. ECE-1 protein localization in the pudendal artery wall. Rat pudendal arteries aged 15 weeks 
(A) and 80 weeks (B) displayed ECE-1 protein localized primarily to the adventitial layer. Pudendal 
arteries were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were 
then immunostained for ECE-1 and detected with a secondary antibody conjugated to Alexa Fluor 546 
(red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent 
microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantitative analysis of ECE-1 protein expression in the pudendal arteries 
revealed a large significant increase in expression with increasing age in the adventitial 
layer, but a non-significant decrease in expression in the medial layer (Figure 31). At 
each time point, the level of ECE-1 expression was greater in the adventitia than in the 
media (Figure 31). 
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Figure 31. Quantitative analysis of ECE-1 protein expression in the pudendal artery wall. ECE-1 
protein expression did not differ significantly across time points in the medial layer (filled bars). However, 
ECE-1 protein expression was significantly greater in at 80 weeks of age as compared to 15 weeks in the 
adventitia (open bars). At both time points, ECE-1 expression was significantly greater in the adventitia as 
compared to the medial layer. Data are expressed as mean ± SEM. Data were analyzed by Student’s t-test.  
*p<0.05 vs. 15wks group, #p<0.05 vs. corresponding adventitia; N=5-6 per group. 
 
4.3.3.3 ETA receptor  
 Expression of the ETA receptor in the pudendal arteries followed a similar pattern 
as exhibited in the aortic and mesenteric artery sections, displaying no apparent 
localization to any specific layer (Figure 32). 
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Figure 32. ETA receptor protein localization in the pudendal artery wall. Rat pudendal arteries aged 15 
weeks (A) and 80 weeks (B) displayed ETA receptor protein localized throughout the mesenteric artery 
wall. Pudendal arteries were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. 
Samples were then immunostained for ETA receptor and detected with a secondary antibody conjugated to 
Alexa Fluor 546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon 
fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Further quantitative analysis of ETA receptor protein expression in the pudendal 
arteries revealed a large significant decline in expression with increasing age in the 
adventitial layer while exhibiting no change in the medial layer (Figure 33). At 15 weeks 
of age, ETA receptor expression was significantly greater in the adventitia compared to 
the media, but no such difference existed at 80 weeks (Figure 33). 
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Figure 33. Quantitative analysis of ETA receptor protein expression in the pudendal artery wall. ETA 
receptor expression was significantly lower at 80 weeks of age as compared to 15 weeks in the adventitia 
(open bars) and the media (filled bars). ETA receptor expression was significantly greater in the adventitia 
compared to the media at 15 weeks, but did not differ significantly at 80 weeks. Data are expressed as mean 
± SEM. Data were analyzed by Student’s t-test.  *p<0.05 vs. 15wks group, #p<0.05 vs. corresponding 
adventitia; N=5 per group. 
 
4.3.3.4 ETB receptor 
 Expression of ETB receptor protein in the pudendal artery wall followed a similar 
pattern as in the aorta and mesenteric arteries, with a high degree of localization in the 
adventitial layer (Figure 34). 
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Figure 34. ETB receptor protein expression in the pudendal artery wall. Rat pudendal arteries aged 15 
weeks (A), 30 weeks (B), 50 weeks (C), and 80 weeks (D) expressed the ETB receptor abundantly in the 
adventitia.  Pudendal arteries were isolated, formalin fixed, embedded in paraffin and serially sectioned at 
5μm. Samples were then immunostained for ETB receptor and detected with a secondary antibody 
conjugated to Alexa Fluor 546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed 
under a Nikon fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantitative analysis of ETB receptor protein expression revealed a small 
significant rise in expression in the adventitial layer from 15 to 80 weeks (Figure 35). 
Contrarily, expression in the medial layer exhibited a small significant decline from 15 to 
80 weeks (Figure 35). At each time point, expression of ETB receptor protein was higher 
in the adventitial layer than in the corresponding medial layer (Figure 35). 
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Figure 35. Quantitative analysis of ETB receptor protein expression in the pudendal artery wall. ETB 
receptor expression was significantly greater at 80 weeks of age as compared to 15 weeks in the adventitia 
(open bars) but was significantly lower at 80 weeks of as compared to 15 weeks of age in the media (filled 
bars). ETB receptor expression was significantly greater in the adventitia than in the media at each time 
point. Data are expressed as mean ± SEM. Data were analyzed by Student’s t-test.  *p<0.05 vs. 15wks 
group, #p<0.05 vs. corresponding adventitia; N=6 per group. 
 
4.4 Oxidative Damage, Extracellular Matrix and Myofibroblast Induction 
 
4.4.1 Oxidative Damage 
 Expression of the oxidative stress marker, 3-nitrotyrosine, was not localized to 
any layer or compartment of the aortic wall, and was spread throughout the vessel wall 
(Figure 36). 
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Figure 36. 3-Nitrotyrosine localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks (B), 
50 weeks (C), and 80 weeks (D) exhibited 3-nitrotyrosine throughout the vessel wall.  Thoracic aortas were 
isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then 
immunostained for 3-nitrotyrosine and detected with a secondary antibody conjugated to Alexa Fluor 488 
(green). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent 
microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Further examination of 3-nitrotyrosine expression revealed somewhat higher 
expression in the medial layer however this was inconsistent across age groups. 
Expression was greatest in the adventitia at 15 and 50 weeks, but declined at 30 and 80 
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weeks, although not significantly (Figure 37). Expression of 3-nitrotyrosine in the medial 
layer remained consistent at 15, 30 and 50 weeks, but declined sharply at 80 weeks, 
although not significantly (Figure 37). Expression of 3-nitrotyrosine did not differ 
significantly between the adventitial and medial layers at all time points (Figure 37). 
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Figure 37. Quantitative analysis of 3-nitrotyrosine content in the aortic wall. 3-Nitrotyrosine displayed 
inconsistent expression in the adventitia (open bars) and the media (filled bars) with increasing age. 
Expression did not differ significantly between age groups in either layer. Similarly, expression did not 
differ significantly between layers at all time points. Data are expressed as mean ± SEM. Data were 
analyzed by ANOVA with a Tukey’s post-hoc test. N=4 per group. 
 
4.4.2 Extracellular Matrix Expression 
 
4.4.2.1 Fibronectin 
 As expected the expression of fibronectin in the aorta was highly localized to the 
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adventitia, although expression was clearly present in the media (Figure 38). 
 
Figure 38. Fibronectin protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks 
(B), 50 weeks (C), and 80 weeks (D) expressed fibronectin abundantly in the adventitia, peaking at 50 
weeks of age.  Thoracic aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 
5μm. Samples were then immunostained for fibronectin and detected with a secondary antibody conjugated 
to Alexa Fluor 488 (green). Nuclei were visualized using DAPI (blue). Samples were viewed under a 
Nikon fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Quantitative analysis of fibronectin expression in the aorta revealed consistent 
expression in the media across all age groups (Figure 39). On the other hand, expression 
 99 
 
in the adventitia rose consistently from 15 through 50 weeks, before declining 
significantly at 80 weeks (Figure 39). At all time points, expression of fibronectin was 
greater in the adventitia than in the media, and was significantly so at 30 and 50 weeks of 
age (Figure 39). 
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Figure 39. Quantitative analysis of fibronectin protein expression in the aortic wall. In the adventitia 
(open bars), fibronectin protein expression increased with age from 15 to 50 weeks of age, with 
significance being reached at 50 weeks compared to 15 weeks. Fibronectin protein expression did not differ 
significantly with increasing age in the medial layer (filled bars). Fibronectin expression was significantly 
greater in the adventitia compared to the media in the 30 and 50 week old groups (p<0.05). Data are 
expressed as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s post-hoc test. *p<0.05 vs. 
15wks groups, #p<0.05 vs. corresponding adventitia; N=5-7 per group. 
 
 Expression of fibronectin in the mesenteric arteries showed a similar pattern to 
that of the aorta, with a somewhat high degree of localization to the adventitia, but still 
displaying positive expression in the medial layer (Figure 40).
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Figure 40. Fibronectin protein localization in the mesenteric artery wall. Rat mesenteric arteries aged 
15 weeks (A), 30 weeks (B), 50 weeks (C) and 80 weeks (D) all expressed fibronectin abundantly in the 
vascular adventitia. Mesenteric arteries were isolated, formalin fixed, embedded in paraffin and serially 
sectioned at 5μm. Samples were then immunostained for fibronectin and detected with a secondary 
antibody conjugated to Alexa Fluor 488 (green). Nuclei were visualized using DAPI (blue). Samples were 
viewed under a Nikon fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
4.4.2.2 Collagen 
 Collagen type I expression in the aorta was localized primarily to the adventitia, 
with much less expression in the medial layer. Unlike fibronectin expression, collagen 
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type I was not expressed to a significant degree in the media (Figure 41). 
 
Figure 41. Collagen type I protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 
weeks (B), 50 weeks (C), and 80 weeks (D) expressed collagen type I abundantly in the adventitia.  
Thoracic aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples 
were then immunostained for collagen type I and detected with a secondary antibody conjugated to Alexa 
Fluor 546 (red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon 
fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
 
 Further examination showed higher collagen type I expression in the aortic 
adventitia at 15, 30 and 50 weeks, with less in the adventitia of the 30 week old aortas, 
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although this difference was not significant. Expression of collagen type I in the media 
was consistently low across all age groups (Figure 42). Expression of collagen type I was 
consistently higher in the adventitia than in the media at all time points, significantly so at 
50 and 80 weeks of age (Figure 42). 
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Figure 42. Quantitative analysis of collagen type I protein expression in the aortic wall. Collagen type 
I was expressed strongly in the adventitial layer (open bars) at 15, 50 and 80 weeks, but was somewhat 
weaker at 30 weeks, while expression in the media (filled bars) was low at all age groups. Furthermore, 
collagen type I expression was significantly higher in the adventitia compared to the media in the 50 and 80 
week old groups. Data are expressed as mean ± SEM. Data were analyzed by ANOVA with a Tukey’s 
post-hoc test.  #p<0.05 vs. corresponding adventitia; N=4 per group. 
 
 As with the aorta, expression of collagen type I was greatest in the adventitia of 
the mesenteric arteries, and not expressed to a major degree in the medial layer (Figure 
43). 
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Figure 43. Collagen type I protein localization in the mesenteric artery wall. Rat mesenteric arteries 
aged 15 weeks (A), 30 weeks (B), 50 weeks (C) and 80 weeks (D) all expressed collagen type I abundantly 
in the vascular adventitia. Mesenteric arteries were isolated, formalin fixed, embedded in paraffin and 
serially sectioned at 5μm. Samples were then immunostained for collagen type I and detected with a 
secondary antibody conjugated to Alexa Fluor 546 (red). Nuclei were visualized using DAPI (blue). 
Samples were viewed under a Nikon fluorescent microscope with a 40X objective lens. Scale bars 
represent 100μm. 
 
4.4.3 Myofibroblast Induction 
 As expected α-SMA expression in the aortic wall was greatest in the medial layer, 
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with much less expression displayed in the adventitia (Figure 44). 
 
Figure 44. α-Smooth muscle actin protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 
30 weeks (B), 50 weeks (C), and 80 weeks (D) expressed α-smooth muscle actin primarily in the media, 
but only sporadically in the adventitia.  Thoracic aortas were isolated, formalin fixed, embedded in paraffin 
and serially sectioned at 5μm. Samples were then immunostained for α-smooth muscle actin and detected 
with a secondary antibody conjugated to Alexa Fluor 488 (red). Nuclei were visualized using DAPI (blue). 
Samples were viewed under a Nikon fluorescent microscope with a 40X objective lens. Scale bars 
represent 100μm. 
 
 Further examination revealed consistently low expression of α-SMA in the aortic 
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adventitia across all age groups. However, expression in the medial layer remained 
relatively constant from 15 through 50 weeks, before increasing significantly at 80 weeks 
(Figure 45). Expression of α-SMA was consistently significantly higher in the medial 
layer than in the adventitia at all time points (Figure 45). 
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Figure 45. Quantitative analysis of α-smooth muscle actin protein expression in the aortic wall. α-
Smooth muscle actin was expressed robustly in the medial layer (filled bars) at all age groups and displayed 
significantly greater expression at 80 weeks compared to all other age groups. Expression in the adventitia 
(open bars) was low in all age groups. Expression of α-smooth muscle actin was significantly greater in the 
medial layer compared to the adventitial layer at all time points. Data are expressed as mean ± SEM. Data 
were analyzed by ANOVA with a Tukey’s post-hoc test.  *p<0.05 vs. 15wks group, #p<0.05 vs. 
corresponding adventitia; N=7 per group. 
 
 Similar to the expression of α-SMA in the aorta, expression in the mesenteric 
arteries was localized primarily to the medial layer, with comparatively much less 
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expression displayed in the adventitia (Figure 46).
 
Figure 46. α-Smooth muscle actin protein localization in the mesenteric artery wall. Rat mesenteric 
arteries aged 15 weeks (A), 30 weeks (B), 50 weeks (C) and 80 weeks (D) expressed α-smooth muscle 
actin primarily in the media, but only sporadically in the adventitia. Mesenteric arteries were isolated, 
formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then immunostained for 
α-smooth muscle actin and detected with a secondary antibody conjugated to Alexa Fluor 488 (green). 
Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent microscope 
with a 40X objective lens. Scale bars represent 100μm. 
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5: Discussion 
The findings of this study have positioned the vascular adventitia as a major 
player in the mediation of age-related vascular diseases. By far the most intriguing 
finding of this study is the extremely high expression of ECE-1 in the adventitia, raising 
the possibility that the adventitia is capable of expressing and releasing more ET-1 than 
any other vascular compartment, including the endothelium. Furthermore, the majority of 
ET-1 immunoreactivity was found in the medial layer, suggesting that ET-1 produced by 
the adventitia is capable of migrating to the media, where it may presumably signal 
vasoconstriction, or growth responses. Additionally the ET receptor heterogeneity found 
in the vessel wall was quite unexpected while also tremendously remarkable. The 
majority of ETA receptor immunoreactivity was found in the media, as expected, but a 
high amount of ETB receptor immunoreactivity was found in the adventitia, suggesting a 
role for the adventitia in vascular ET-1 regulation. Taken together, these results have 
revealed the adventitia to be a potentially vital tissue in the mediation of vascular disease. 
Cell marker analysis of the tissue sections has revealed that the adventitial layer is 
not comprised of significant amounts of stem cells, endothelial cells, smooth muscle 
cells, myofibroblasts, or macrophages. Thus, it is likely that the adventitial layer of these 
tissue sections is comprised primarily of fibroblast cells. Most notably this study has 
demonstrated that the rat vascular adventitia is capable of growing at a rate that is equal 
to or greater than the growth of the vascular wall, as well as the medial smooth muscle 
layer over an 80 week time span. Thus, the proteins and factors expressed by the 
adventitia may have an equal impact at young ages as in old ages. In addition this study 
has clearly demonstrated the robust expression of ET system proteins in the vascular 
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adventitia, and implicated the adventitia in the maintenance vascular tone. Furthermore, 
this study has shown a steady increase in ECM deposition over the course of the 80 week 
time span, emphasizing the known contribution of the adventitia to vascular structure, but 
also highlighting the adventitia’s capability to affect vascular stiffness. 
 
5.1 Vascular Structural and Morphological Changes during Aging  
 
5.1.1 Aorta 
 Analysis of aortic sections revealed overt structural changes in the vessel wall 
with increasing age. As shown in Table 1, the aortic wall significantly increased in 
thickness and CSA with increasing age both in terms of the adventitial and medial layers. 
This thickening eventually led to an increase in wall to lumen ratio at 80 weeks (Table 1), 
despite the fact that lumen diameter actually increased significantly over that time. This is 
consistent with previous literature regarding the large central elastic conduit arteries, 
which exhibit increased wall thickness, CSA and stiffness as well as increased lumen 
diameter with increasing age (Hannan, et al., 2010; Hashimoto & Ito, 2009). Although 
measurement of arterial stiffness is not possible in these tissue sections, it would be easy 
to speculate that such a dramatic increase in wall thickness would accompany a 
corresponding increase in stiffness of the aorta. Similar studies of arterial aging have 
shown an increase in large artery stiffness with similar thickening of the arterial wall 
(Blough, Rice, Desai, Wehner, & Wright, 2007; Santelices, Rutman, Prantil-Baun, Vorp, 
& Ahearn, 2008). 
 Of note in this study is that the contribution of the adventitia to aortic wall 
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thickening with aging has been shown, without focussing solely on the contribution of the 
intima-media. These data show clearly that the adventitial layer of the aortic wall 
increases in thickness at a rate that matches the growth of the medial layer (Table 1). 
Many sources have suggested that the increase in large artery stiffness with increasing 
age is directly related to a thickening of the intima-media, in addition to structural 
changes in the organization of the medial layer (Hashimoto & Ito, 2009; Nichols, et al., 
2008; O'Rourke & Hashimoto, 2007). With similar morphological changes occurring in 
the adventitia with increasing age, it may be argued that the aortic adventitia contributes 
to age-related central artery stiffness in equal magnitude as that of the medial layer. 
(Hannan, et al., 2010) 
 
5.1.2 Mesenteric Arteries 
 Unlike the aorta, the morphological changes in the mesenteric arteries with 
increasing age did not occur in a consistent fashion. The overall increase in wall 
thickness and CSA of the mesenteric arteries from 15 to 80 weeks of age did not follow 
the same consistent pattern that was seen in the aorta. An overall increase in wall 
thickness and lumen diameter in the mesenteric arteries with increasing age has been 
demonstrated before (Laurant, et al., 2004; Moreau, et al., 1998), however it has been 
noted that the small muscular mesenteric arteries experience less strain in aging as do 
large elastic conduit arteries and thus manifest less overt morphological changes over 
time (Hashimoto & Ito, 2009). This discrepancy is likely due to the difference in elastic 
properties between these two types of vessels, with the small muscular arteries possessing 
more distensibility than the large elastic arteries, and are thus subject to less cyclic strain 
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over a given period of time (Hashimoto & Ito, 2009). 
 Another possible explanation for the discrepancy in mesenteric artery 
morphometry with aging may relate to the heterogeneity of the animals used. Although it 
is generally assumed that a rat of a particular strain will be the same no matter when it 
was obtained, this simply is not the case. Since each of the separate age cohorts were 
obtained and raised at separate times, there may exist some differences between 
individual groups of animals. It has been shown previously that male Sprague-Dawley 
rats exhibit large variation in avoidance behaviour (Cure & Rolinat, 1992), spatial 
memory (Ghirardi, Giuliani, Caprioli, Ramacci, & Angelucci, 1992), and anxiety 
response (Prasad, Henry, & Prasad, 1996). Although no research has examined possible 
cardiovascular aging heterogeneity in these rats, it remains a definite possibility, and may 
explain the discrepancy of the changes observed in the mesenteric artery wall in this 
study. 
 Also unlike the aorta, the mesenteric arteries exhibited a much different 
relationship in adventitia to media thickness ratio with increasing age. Whereas the aortic 
adventitia to media thickness ratio remained constant from 15 to 80 weeks of age, the 
mesenteric adventitia to media thickness ratio increased significantly from 15 to 30 
weeks, and then fell below the control level, reaching a significant difference at 80 weeks 
of age (Table 2). This perhaps illustrates a very basic difference between the central 
elastic conduit arteries and the peripheral muscular arteries. The central elastic conduit 
arteries are subject to much greater cyclic strain over a given time period, and thus 
require a greater reserve of extracellular matrix in the adventitia to handle the stretch 
stimulus effectively. Thus, the aortic adventitia grows with the rest of the vessel wall and 
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the lumen diameter to accommodate this enhanced strain over time. The muscular 
mesenteric arteries experience far less cyclic strain, and thus have less need for a robust 
supply of ECM from the adventitia. Despite a slower rate of growth for the mesenteric 
adventitia when compared to the medial layer, the adventitia was significantly thicker at 
all time points. Coupled with previous findings showing an increase in the number of 
mesenteric artery adventitial cells with aging (Briones, et al., 2007), and hypertension 
(Kantachuvesiri, et al., 2001), this would suggest another important role for the 
mesenteric artery adventitia. 
 
5.1.3 Pudendal Arteries 
 The morphological changes seen in the pudendal arteries with increasing age are 
similar to those seen in the aorta and mesenteric arteries, exhibiting an overall increase in 
wall thickness and CSA over time. The change in wall to lumen ratio from 15 to 80 
weeks was most significant in the pudendal arteries, yielding aged vessels which have 
grown at a rate far exceeding the growth of the lumen diameter. This can likely be 
explained by the concomitant rise in mean arterial pressure in the large elastic and small 
muscular arteries preceding the small resistance vessels such as the pudendals. In order to 
maintain steady blood flow to organs and tissues, the resistance vessels must dampen the 
pressure entering these vessels and acutely control it through vasoconstriction (James, et 
al., 1995; O'Rourke & Safar, 2005). This would explain the massive increase in medial 
wall thickness and CSA with increasing age, as the acute control of vasoconstriction is 
performed by the medial smooth muscle. 
 Despite the tremendous increase in medial wall thickness with increasing age, the 
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pudendal artery adventitia exhibits no significant change in thickness over time (Table 3). 
However, adventitia CSA increased slightly over time, showing that the pudendal 
adventitia does not remain completely dormant. This is consistent with previous findings 
which showed that the small resistance vessels are capable of maintaining a high degree 
of arterial compliance in the face of elevated distending pressure through smooth muscle 
hypertrophy rather than collagen deposition (Hayoz, et al., 1992; Laurent, 1995; Laurent, 
et al., 1994; Mourad, Girerd, Boutouyrie, Safar, & Laurent, 1998). Thus it is likely that 
the morphological changes seen in the pudendal artery wall with increasing age reflect 
this pathway with a tremendous increase in medial layer thickness, but no such change in 
adventitial layer thickness. 
 
5.1.4 The Arterial Tree 
 On a whole the data presented in this study illustrate the interconnectedness of the 
arterial tree along with its distinctly different structural regions including the central 
elastic conduit arteries, the peripheral muscular arteries, and the small resistance vessels. 
The pressure load increase experienced in aging leads to a decrease in compliance and 
resistance of the central elastic conduit arteries which is manifested here in terms of an 
increase in both aortic wall thickness and lumen diameter. This in turn results in greater 
flow and pressure exerted on the peripheral muscular arteries, which adapt by increasing 
wall thickness, a by-product of which is decreased compliance (Mitchell, 2008). This 
results in higher distending pressure exerted on the small resistance vessels, which 
compensate through medial smooth muscle hypertrophy in order to provide enhanced 
temporal control of local blood flow while maintaining normal distensibility (Mitchell, 
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2008). However, the increased resistance to blood flow produced here results in a larger 
reflected wave of pressure in the more proximal vessels. Combine this with the enhanced 
stiffening of these large vessels, and the reflected wave travels fast enough to arrive in 
close proximity to the forward wave, resulting in a huge increase in systolic and pulse 
pressures. These in turn drive the ‘vicious cycle’ forward, further exacerbating the 
structural changes displayed here (Laurent, Briet, & Boutouyrie, 2009). 
 The role of the vascular adventitia in this process can be seen in a gradient of 
influence from a high degree in the elastic aorta, to a lesser extent in the muscular 
mesenteric arteries, to a near nil effect in the resistant pudendal arteries. This is evidenced 
by the change in adventitial wall thickness and adventitia to media thickness ratio with 
increasing age in each of these vessel types. In the aorta, the adventitia grows at a 
consistent rate over time, matching the rate of growth of the medial layer, likely 
reflecting the need of the aorta for reinforcing extracellular matrix structural support 
produced by the adventitia. In the mesenteric arteries, this same relationship is seen early 
on, from 15 to 30 weeks of age, but it reverses thereafter, with the medial layer outpacing 
the growth rate of the adventitia. It is possible that these vessels are capable of adapting 
to the increased pressure load first by reinforcing extracellular matrix components to 
maintain integrity of the vessel wall in the face of substantial cyclic stretch, but then 
change this adaptation to medial smooth muscle hypertrophy in order to maintain 
distensibility and thus flow to adjacent capillary beds and vital organs. In the pudendal 
arteries, this relationship is shifted entirely towards VSMC hypertrophy, resulting in 
much faster growth of the medial layer as compared to the adventitial layer over time. 
However, it should be noted that with the absence of the 30 and 50 week time points in 
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these vessels, it would be impossible to ascertain if this relationship is consistent from 15 
to 80 weeks of age, or is in fact very similar to the peaked relationship seen in the 
mesenteric arteries. 
 
5.2 The Role of Cell Hypertrophy, Proliferation and Apoptosis During Vascular 
Aging 
 This study has shown that VSMCs and ECs are not the only vascular cell types 
that undergo hypertrophy with aging, and in fact the adventitial cells (most likely 
fibroblasts) also grow in overall size with increasing age. Additionally, aortic adventitial 
cells appear to proliferate at a higher rate than any other vascular cell, and do not undergo 
significant apoptosis, yielding a more substantial adventitial layer later in life. 
 
5.2.1 Cell Hypertrophy 
 
5.2.1.1 Aorta 
 Aortic medial and adventitial cells increased in overall size with increasing age. 
In both cases, the increase in size was biphasic, first increasing significantly from 15 to 
30 weeks of age, before dropping slightly at 50 weeks, and then rising again at 80 weeks 
(Figure 5). The increase in aortic cell size follows a similar increase in aortic wall 
thickness both in the adventitial and medial layers. It has been previously established that 
VSMCs undergo hypertrophy in aging (Dinenno, et al., 2000; Izzo & Mitchell, 2007), 
and hypertension (Laurent, 1995; Mourad, et al., 1998). Additionally it has been shown 
that the adventitia displays an overall increase in the number of cells residing in that layer 
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with increasing age (Briones, et al., 2007). However, the novelty of this study is in the 
demonstration of hypertrophy occurring in the adventitia. The logical cause of this 
phenomenon is likely the increase in cyclic strain experienced in the aorta, leading to 
damage of the elastic lamellar units, and an increase in ECM deposition by the adventitia 
to compensate. A resultant increase in adventitial hypertrophy is merely a symptom of the 
disease. 
 
5.2.1.2 Mesenteric Arteries 
 The medial and adventitial cells of the mesenteric arteries also exhibit some 
hypertrophy with increasing age, but with a different pattern from the aorta. As in the 
aorta, the cells of the mesenteric artery adventitia also exhibit a biphasic increase in 
overall size with increasing age. However, the mesenteric adventitial cells reach their 
maximal size at 30 weeks whereas the aortic adventitial cells do not reach their maximal 
size until 80 weeks of age. The medial mesenteric artery cells, on the other hand, remain 
at an equal size from 15 to 50 weeks of age before growing significantly at 80 weeks. 
Again, the changes in overall cell size closely follow the changes in wall thickness in the 
mesenteric arteries. The mesenteric arteries appear to exhibit a biphasic response to the 
increased pressure load experienced in aging. This would appear to be in agreement with 
previous findings of increased contractile sensitivity of the mesenteric arteries in very old 
rats (Blough, et al., 2007; Moreau, et al., 1998). This is also in agreement with a previous 
finding showing a recovery in the elastic modulus of the aorta between old and very old 
rats (Laurant, et al., 2004), presumably to enhance distensibility to better accommodate 
the increased pressure load seen in aging. Thus, the mesenteric arteries appear to adapt to 
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increased blood pressure first by reinforcing ECM by the adventitia and secondly by 
enhancing the medial smooth muscle layer to maintain distensibility. 
 
5.2.1.3 Pudendal Arteries 
 The pudendal arteries display a small non-significant increase in overall cell size 
in the adventitial layer, but a greater significant increase in overall cell size in the medial 
layer (Figure 7). In regards to the adventitial layer, this result is consistent with the 
observed increase in thickness with increasing age. The pudendal arteries are required to 
remain distensible in the face of rising arterial pressure, and thus do not display a large 
increase in adventitial size, which would increase vascular stiffness through the 
deposition of ECM. The change in medial cell size is also consistent with the increase in 
thickness of the medial wall; however, with nearly a 4-fold increase in medial wall 
thickness with increasing age (Table 3), one would expect a larger increase in cell size 
than that observed (Figure 7). Thus it would appear that the pudendal artery medial wall 
grows through cell proliferation in aging, rather than by extensive hypertrophy. Although 
studies regarding the pudendal arteries in aging are sparse, a recent example is consistent 
with the findings reported here (Hannan, et al., 2010). The pudendal artery is subject to 
large changes in arterial pressure, especially during copulation, thus the huge increase in 
medial wall hypertrophy may enable the pudendal artery wall to distend under this high 
pressure to maintain adequate flow. 
 
5.2.1.4 The Arterial Tree 
 Overall, the morphological changes observed in each vessel type during aging 
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relate both to their individual purposes in the vasculature as well as their 
interconnectedness. The aorta experiences much greater hypertrophy of the adventitial 
layer which is sustained through the aging process due to the very high pressures exerted 
on it, and the subsequent damage inflicted on the medial smooth muscle from cyclic 
strain. The mesenteric arteries experience a somewhat biphasic response to aging, 
initially displaying a lot of hypertrophy in the adventitial layer, which then declines and 
allows the lagging medial layer hypertrophy to overtake it. The initial increase in 
adventitia is likely caused by the large increase in mean pressure from the stiffened aorta 
by much the same mechanism as in the aorta itself. However, as the animal ages, the need 
for the mesenteric arteries to distend in the face of chronically elevated arterial pressure is 
apparent and the medial smooth muscle grows to meet this need accordingly. In the 
pudendal arteries, the need for distensibility is ever apparent, even at relatively younger 
ages, thus the increase in medial wall thickness and cell size is more dramatic than in the 
mesenteric arteries, while little change is observed in the adventitial layer. However, it 
should be noted that the changes in the pudendal arteries may be occurring in a similar 
manner as in the mesenteric arteries, but without the intermediate time points available in 
these vessels this aspect is impossible to determine. 
 
5.2.2 Cell Proliferation 
 The expression of the cell proliferation marker Ki67 displayed a significant rise 
with increasing age in the aortic adventitial layer (Figures 9 & 10). More interesting is the 
fact that expression of Ki67 was localized primarily to the adventitial layer, exhibiting 
very little expression in the medial layer. This data is consistent with the morphological 
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changes seen in the aortic adventitial layer with increasing age, which exhibits an age-
dependent rise in thickness (Table 1) and cell size (Figure 6). This data is again consistent 
with previous findings which suggest a thickening and stiffening of the aorta in aging as a 
compensatory mechanism to adapt to rising cyclic strain over time (Astrand, Ryden-
Ahlgren, Sandgren, & Lanne, 2005; Blough, et al., 2007; Mitchell, 2008). The rising 
expression of Ki67 with aging merely reflects another mechanism by which the aortic 
wall compensates for and adapts to the age-dependent rise in arterial pressure and wall 
stress. 
 
5.2.3 Cell Apoptosis 
 Defying all expectations, the aorta sections examined here exhibited almost zero 
expression of the apoptosis marker cleaved caspase-3. Apoptosis is a very common 
process in numerous aging cell populations (Asai, et al., 2000; Hoffmann, et al., 2001; 
Intengan & Schiffrin, 2001; Torella, et al., 2004). Furthermore, previous research has 
found that aging increases the sensitivity of aortic VSMCs (Schauer, et al., 2010) and 
ECs (Hoffmann, et al., 2001) to apoptosis or apoptotic stimuli. So it would seem that the 
data presented here do not represent the consensus knowledge on apoptosis in arterial 
aging. However, in many studies examining apoptosis, acute injurious stimuli are utilized 
to induce changes in gene expression, which often lead to apoptosis. In this study, no 
such stimuli were experienced, and the tissue displayed here exhibit the result of chronic 
stress over a long period of time. Additionally, the process of apoptosis is ongoing in all 
tissues, not just in aging, and thus may not be fully described in isolated single time 
points such as in this study. 
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Further examination with the caspase-3 antibody showed a similarly low amount of 
apoptosis in aorta sections isolated from a hypertensive mouse (Figure A-4), a model 
known to induce apoptosis (Intengan & Schiffrin, 2001). Thus, it is likely that the method 
used to detect apoptosis is not sufficiently sensitive. Alternatively, these tissues could be 
undergoing apoptosis that is caspase-3 independent, although previous attempts at 
detecting apoptosis using the TUNEL assay were unsuccessful as well. 
 
5.2.4 The Interplay of Cell Hypertrophy, Proliferation and Apoptosis in Vascular 
Aging 
 Overall, the changes observed in the aging vasculature in regard to cell 
hypertrophy, proliferation and apoptosis reflect the local arterial pressure changes 
occurring in aging. As blood pressure increases with time due to arterial wall damage and 
stiffening, the arterial tree adjusts to accommodate these factors. The arterial walls grow 
thicker, while the cells proliferate and grow in size to better handle the chronic wall stress 
exerted by high blood pressure. The changes seen in these vessels may seem pathogenic; 
however they are simply a necessary evil needed to maintain arterial blood flow and 
perfusion of tissues. 
 
5.3 The Role of Endothelin System Expression in Vascular Aging 
 This study has shown for the first time an active and strong ET system in the 
vascular adventitia. Not only do ET system proteins localize to the adventitia, but they 
are often expressed to a greater degree here than in the intimal or medial layers. Given 
the tremendous influence of ET-1 in the vasculature on cell growth, proliferation, and 
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vascular tone, the implications of these data are potentially quite profound. 
 
5.3.1.1 ET-1 
 ET-1 expression in the aorta, mesenteric arteries, and pudendal arteries was 
spread throughout the vessel wall, with somewhat greater localization to the medial layer 
(Figures 12, 20, & 28, respectively). In the aorta, with increasing age, ET-1 expression 
remained constant in the medial layer, but fluctuated in the adventitial layer (Figure 13). 
A similar pattern of expression was found in the mesenteric arteries with increasing age 
(Figure 21). These data present interesting evidence since the antibody used to detect ET-
1 expression detects the BigET-1 isoform of ET-1 specifically. The lower amount of 
detectable BigET-1 in the adventitia likely reflects the enhanced ability of this tissue to 
cleave BigET-1 into the mature ET-1 peptide, given the high expression of ECE-1 protein 
in the adventitia. Thus although it would appear expression of ET-1 in the adventitia is 
lower than in the media, taking all factors into account would suggest that the adventitia 
is a more efficient cellular factory of mature ET-1 than the media. However, it is 
interesting to note that expression of ET-1 in the medial layer does not change with 
increasing age in the aorta and mesenteric arteries, suggesting ET-1 is necessary for 
maintaining vascular tone and cell growth in these vessels, which have been 
demonstrated previously (Haynes, et al., 1996; Iemitsu, et al., 2006; Ivey, Osman, & 
Little, 2008; Rodriguez-Vita, et al., 2005). This would also be consistent with the 
morphological data presented in this study, which show that the aortic and mesenteric 
artery walls grow at a steady rate with increasing age, rather than reaching a maximum 
and levelling off. Unfortunately it is impossible to measure vascular contractile and 
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dilatory responses in these sections, but previous studies have shown an alteration in ET-
related vasomotor responses in aging (Donato, Lesniewski, & Delp, 2005; Korzick, et al., 
2005). 
 In the pudendal arteries, ET-1 expression is relatively high in the media and 
adventitia of the 15 week old sections, before dropping off completely at 80 weeks 
(Figure 29). This is in agreement with the ETA receptor data from these vessels (Figure 
33), and morphological data (Table 2), which show a tremendous increase in the medial 
smooth muscle layer and concomitant drop in ETA receptor expression. The protein 
expression changes are likely a functional adaptation to the morphological changes since 
a high degree of ET-1 and ETA receptor expression would result in a high degree of 
vasoconstriction given the thickened medial smooth muscle layer. Alternatively, a high 
production and release of mature ET-1 would drive down expression of the ETA receptor 
through a negative feedback mechanism. 
 Previous data from our lab has shown that ET-1 is involved in type I procollagen 
synthesis in cultured adventitial fibroblasts (An, et al., 2006). Additionally, it has been 
shown that ET-1 can stimulate contractile responses in a tissue-engineered blood vessel 
model comprised entirely of adventitial cells (Laflamme, et al., 2006). Thus the presence 
of the ET-1 peptide in the adventitial layer may serve to activate these pathways, 
combining to stiffen and strengthen the aortic wall in the face of rising arterial pressures. 
The fact that detectable ET-1 declines with aging in the adventitia may be an artefact of 
the tissue isolation and preservation procedure, or may reflect the clearance mechanism 
exhibited by the high expression of the ETB receptor in the adventitia of the aorta, 
mesenteric arteries, and pudendal arteries (Figures 18, 26, & 34, respectively). 
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5.3.1.2 ECE-1 
 The most striking result of this study lies in the localization of ECE-1 protein to 
the vascular adventitia of the aorta, mesenteric arteries, and pudendal arteries, as shown 
in Figures 14, 22, and 30, respectively. It has long been established that ET-1 is produced 
by vascular endothelial cells and that ECE-1 is highly expressed in these cells (Hickey, et 
al., 1985; Yanagisawa, et al., 1988). This is consistent with the present data, which shows 
a thin band of ECE-1 localization in the endothelium. However, expression of ECE-1 in 
the endothelium is inconsistent since many sections appear to be lacking endothelial 
cells, which may have been removed during the isolation procedure, or by high arterial 
pressures. Nevertheless, expression of ECE-1 is still greater in the adventitia, even when 
intact endothelium is present. 
 Localization of ECE-1 to the adventitia is consistent with our previous data 
showing expression and release of ET-1 from cultured adventitial fibroblasts (An, et al., 
2006). However, our data would suggest that the amount of ET-1 that adventitial 
fibroblasts express and release is similar to previously published figures for VSMCs (A. 
W. A. Hahn, et al., 1990), but far less than figures published for ECs (Ozaki, et al., 1995). 
This would appear to be in contrast to the data presented here, which would suggest that 
the adventitia, above all other vascular wall components, possesses the greatest capacity 
for expressing and releasing ET-1. Of course this discrepancy could be explained by 
differences between the previously published in vitro data and the in vivo data presented 
here. It is possible that in a monoculture of adventitial fibroblasts, with the absence of a 
paracrine signal arising from the endothelium or medial smooth muscle, the adventitial 
cells simply have no need for synthesizing and releasing ET-1. On the other hand, 
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expression of ECE-1 does not necessarily correlate with ET-1 release, although 
expression of such a high level of ECE-1 would be quite energetically wasteful if it did 
not serve such a purpose. It should be noted that with such a high level of expression of 
ECE-1, the adventitia may possess the capability of controlling ET-1 content of the 
vascular wall, and have the ability to override ET-1 secretion by any other vascular wall 
component. Whereas the consensus knowledge would contend that the vascular 
endothelium is the main source of ET-1 in the vasculature, these data would suggest that 
the adventitia can overcome the endothelium in this regard. 
 
5.3.1.3 ETA 
 Although expressed in the adventitia, the expression of the ETA receptor was 
localized primarily to the medial layer of the vessels examined (Figures 16, 24, & 32, 
respectively). In the aorta, expression of the ETA receptor was consistently low in the 
adventitia from 15 to 80 weeks of age. On the other hand, expression of the ETA receptor 
in the medial layer rose substantially, at 80 weeks (Figure 17). Meanwhile in the 
mesenteric arteries, expression of the ETA receptor fluctuated with increasing age in both 
the medial and adventitial layers (Figure 25). And finally, expression of the ETA receptor 
in the pudendal arteries displayed a sharp decline from 15 to 80 weeks in both the medial 
and adventitial layers (Figure 33) Given the substantial growth of the adventitia with 
increasing age, it is surprising not to find more ETA receptor protein localized to the 
adventitia since it mediates the main mitogenic responses of ET-1 (Rodriguez-Vita, et al., 
2005; Shi-Wen, et al., 2001). It is entirely possible that the growth and proliferatory 
responses observed in the adventitia with aging are mediated by mitogenic signalling 
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molecules other than ET-1, or these responses are stimulated simply by the wall stress 
exerted by elevated arterial pressure. 
On the other hand, ETA receptor expression in the medial layer of the aorta and 
mesenteric arteries is consistent with previous findings which suggest an increase in ETA-
dependent vasoconstriction in aged vessels (Thijssen, Rongen, van, Smits, & Hopman, 
2007; Van Guilder, et al., 2007). This would also contribute to an increase in aortic wall 
stiffness if the baseline ET-1 related vascular tone is in fact elevated. Additionally, the 
enhanced expression of the ETA receptor with increasing age may relate to connective 
tissue formation in the medial layer (Rodriguez-Vita, et al., 2005). This may occur in 
response to the damage of medial lamellar units during aging, a process which is quite 
common in vascular aging (Connat, et al., 2001). Furthermore, it has been found that the 
ETA receptor may mediate EC adhesion molecule expression, which is caused by 
vascular inflammation, a process likely to be involved in vascular aging (Callera, et al., 
2004). Thus, with many cellular responses mediated by an ETA receptor pathway, even a 
relatively mild change in ETA receptor expression can have a considerable effect on the 
vascular wall. Moreover, with such varying responses mediated by this pathway, a 
similar change in expression in opposing tissues or cell types can have vastly divergent 
effects. In the pudendal arteries, the decline in ETA receptor expression is likely a 
functional adaptation to the massive hypertrophy of the vessel wall to maintain a patent 
dilated vessel under resting conditions. 
 
5.3.1.4 ETB 
 Expression of the ETB receptor localized partly to the endothelium, but primarily 
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to the adventitial layer of the aorta, mesenteric arteries, and pudendal arteries (Figures 18, 
26 & 34, respectively). It has been previously established that the ETB receptor mediates 
vasodilation (Hirata, et al., 1993), ET-1 synthesis down-regulation (Ozaki, et al., 1995), 
clearance of circulating ET-1 (Fukuroda, et al., 1994), and inhibition of NADPH oxidase 
(J. K. Dammanahalli & Z. Sun, 2008) in ECs. It is likely that at least some of these 
functions are present in adventitial cells. Coupled with the simultaneous high expression 
of ECE-1 in these locations, the logical role for the ETB receptor is likely in a negative 
feedback or clearance mechanism. 
 Interesting to note here is that the ETB receptor is expressed to a much greater 
extent than the ETA receptor in the adventitia. This would appear to be in contrast to 
previous findings from an adventitial cell-derived tissue engineered blood vessel 
construct (Laflamme, et al., 2006), and data from our own lab in cultured adventitial 
fibroblasts (An, et al., 2006), which each show a greater abundance of the ETA receptor 
than the ETB receptor. In each of these cases, however, the system being used represents 
a monoculture of adventitial fibroblasts, and thus would lack any potential paracrine 
signals arising from neighbouring cell types. Such potential paracrine signals may be 
necessary for adventitial fibroblasts to express a significant detectable amount of the ETB 
receptor, and thus may explain the discrepancy in findings. 
 
5.3.4 Overview of the ET System in the Arterial Tree 
 The findings of the present study in regards to ET system expression are very 
striking. For the first time, the present study has demonstrated the robust expression of 
ET system proteins in the vascular adventitia. Additionally, these proteins are not limited 
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to a single vascular bed, as each of the thoracic aorta, mesenteric artery and pudendal 
artery adventitial layers express similar amounts of all 4 ET system proteins. Most 
striking is the expression of ECE-1 to such a great degree in the adventitia. Conventional 
wisdom has maintained that the endothelium contains the highest concentration of ECE-1 
protein, and is capable of releasing the most ET-1 of any cell type in the vascular wall 
(Ozaki, et al., 1995). The results of the present study would appear to refute that claim, 
and would suggest that the adventitia possesses the capability to synthesize and release 
far more ET-1 than any other vascular cell type. Considering the activity of ET-1 in 
controlling vascular tone by acting on VSMCs (Haynes, et al., 1996), from an 
architectural standpoint, this finding would make perfect sense. It is unlikely that the 
endothelium, comprised of cells that are often subjected to injurious stimuli based on 
their location, would alone be capable of synthesizing and releasing enough ET-1 to 
control vascular tone simply because it is adjacent to the medial layer. Thus it only makes 
sense that the adventitia would possess a similar mechanism, also residing adjacent to the 
medial layer. 
 
5.4 The Roles of ROS Content, ECM Expression and Myofibroblast Induction in 
Vascular Aging 
 The processes of ROS production, ECM expression, and myofibroblast induction 
are generally thought to negative consequences of cellular damage repair. The results of 
the present study have presented conflicting data which both support and refute this idea, 
revealing that these processes may not be clear in their purposes. 
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5.4.1 ROS Content 
Although one would expect oxidative stress to increase dramatically with age, the 
data presented here do not support this hypothesis. Instead, 3-nitrotyrosine, a marker of 
cellular oxidative stress displayed its greatest expression between 15 and 50 weeks, and 
declined at 80 weeks, although not significantly (Figure 37). Under identical 
experimental conditions, a significant amount of 3-nitoryrosine could be detected in aorta 
sections isolated from an angiotensin II-infused hypertensive mouse (Figure A-5), a 
model known to induce significant oxidative stress (Wang, et al., 2001). Thus, it is not 
likely that the probe used to detect ROS in this study was not sufficiently sensitive. It has 
been commonplace to assume oxidative stress to increase with aging, thus resulting in an 
accumulation of cellular damage and the common aged phenotype. However, several 
lines of evidence would seem to refute this claim. First, clinical trials with vitamin E 
supplementation, a powerful antioxidant, have resulted in very little positive effect in 
disease prevention (Sesso, et al., 2008). Second, the paradoxical example of the mclk+/- 
mouse, which exhibits much higher levels of oxidative stress, but lives longer than its 
wild-type contemporaries (Lapointe & Hekimi, 2008). And finally, results from the 
present study show a slight decline in overall in collagen type I protein expression after 
age 15 weeks (Figure 42), which our lab has shown to be a ROS dependent pathway in 
adventitial fibroblasts (An, et al., 2007). Thus, the present study may represent part of the 
growing body of evidence refuting a large role for oxidative stress in the aging process. 
Interestingly, the localization of 3-nitrotyrosine in the adventitial layer did not 
differ significantly from the medial layer at any time point (Figure 37). This is in contrast 
with previous findings showing the adventitia to be a rich source of ROS in the vascular 
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wall (Pagano, et al., 1997; Wang, et al., 1999; Wang, et al., 1998). Numerous other 
studies have shown detrimental effects of adventitial-derived ROS in mediating processes 
such as neointimal formation (Dourron, et al., 2005), hyperplasia (Weaver, et al., 2006), 
and VSMC hypertrophy (Liu, et al., 2004). However, each of those studies employed 
acute injurious stimuli to stimulate adventitial ROS production. In the model employed 
here, the vascular adventitia is not exposed to such a similar acute and intense injury, but 
rather is exposed to the mild chronic injury of prolonged cyclic strain. It is possible that 
this weaker stimulus is not sufficient to evoke a large response in terms of ROS 
production. Similarly, the mechanisms for ROS production, such as NADPH oxidase, 
often comprise short-acting, inducible enzymes which produce short, transient bursts of 
ROS. With an isolated view of the vessel wall at individual time points, it is exceedingly 
unlikely to capture one of these transient processes in action. 
 
5.4.2 Extracellular Matrix Expression 
 It has long been established that the arterial walls stiffen during aging in a process 
called arteriosclerosis. One of the common mechanisms for this age-related stiffening is 
the enhanced expression and deposition of ECM proteins. A common consequence of 
ET-1 signalling is the production of ECM proteins, such as collagen. Given the immense 
expression of ECE-1 in the vascular adventitia, the accumulated effects of ET-1 
signalling are likely to be seen in the adventitia, displaying enhanced ECM expression 
during aging. Here, in the present study, the expression of the ECM proteins fibronectin 
and collagen type I have been explored to address the potential change in ECM protein 
expression and deposition with increasing age. 
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5.4.2.1 Fibronectin 
 Fibronectin expression in the aortic adventitia rose steadily and significantly from 
15 to 50 weeks of age before declining at 80 weeks (Figure 39). Meanwhile, expression 
of fibronectin in the medial layer did not change significantly from 15 to 80 weeks of age 
(Figure 39). This discrepancy in fibronectin expression between the adventitial and 
medial layers was fully expected, since fibroblasts produce immense amounts of ECM 
proteins, compared to other common vascular cell types (Gabbiani, 2003). It has also 
been shown that fibronectin expression provides a conduit for fibroblast migration in 
wound repair processes (Briggs, 2005; Greiling & Clark, 1997). Additionally, ET-1 
signalling has been shown to stimulate fibronectin expression in cultured skin fibroblasts 
(Shi-Wen, et al., 2001). Combined with the overall decline in ET-1 expression with 
increasing age, the probable reason for enhanced fibronectin expression during the aging 
process would be for injury repair and fibroblast migration. 
It is possible that the vessel is sufficiently stiffened and reinforced after 50 weeks 
to the point that excessive fibronectin expression is no longer necessary. Alternatively the 
mechanism by which fibronectin expression is activated may be damaged after 50 weeks, 
thus reducing its overall expression. Further experiments would be warranted to elucidate 
the specific cause for this change in expression. A similar expression pattern of 
fibronectin was seen in the mesenteric arteries (Figure 40), suggesting the role of 
fibronectin in aging is not limited to the aorta. 
 
5.4.2.2 Collagen type I 
 The expression of collagen type I in the adventitia remained relatively unchanged 
 130 
 
from 15 to 80 weeks of age in the aorta (Figures 41 & 42). The mesenteric arteries 
displayed a similar preferential localization of collagen type I to the adventitial layer, but 
appeared to show an increased expression at 80 weeks (Figure 43). Numerous studies 
have shown that collagen expression is stimulated in vascular cells by Ang II signalling 
(An, et al., 2006; Boffa, et al., 1999; Che, et al., 2008; Ford, Li, & Pickering, 1999). 
Additionally, ET-1 signalling may also have effects in the stimulation of collagen 
synthesis (An, et al., 2006; Horstmeyer, Licht, Scherr, Eckes, & Krieg, 2005; Shi-Wen, et 
al., 2001). The enhanced expression of collagen in the vasculature is a well established 
phenomenon leading to enhanced age-related vascular stiffness (Izzo & Mitchell, 2007; 
Mitchell, 2008). However, combined with the morphological data presented earlier, the 
overall collagen content may actually remain sufficiently high, despite average 
expression falling with increasing age. 
 
5.4.3 Myofibroblast Induction 
The adventitial layers displayed almost zero expression of α-SMA at all ages, 
suggesting a non-existent level of myofibroblast content (Figure 45). Thus it would 
appear that myofibroblast induction is not a significant factor in vascular aging because it 
is commonly known that fibroblasts undergo phenotypic differentiation to myofibroblasts 
and express α-SMA under high stress conditions such as wound healing (Gabbiani, 
2003). It is likely that the process of aging alone does not present a particularly noxious 
stimulus for the induction of such a phenotypic switch and the adventitial myofibroblast 
content is unchanged. 
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5.4.4 The Interplay of ROS Content, ECM Expression, and Myofibroblast Induction in 
Vascular Aging 
 Overall one would expect ROS content, ECM expression and myofibroblast 
induction to be enhanced during aging, resulting in a damaged, stiffened, and reactive 
aged vascular wall. However, as previous literature has illustrated, the requirement for 
significant induction of each of these processes include particularly noxious stimuli. It is 
likely that the process of vascular aging represents a relatively mild chronic injurious 
stimulus, which is not sufficiently noxious as to induce these energetically expensive 
processes. The consistent changes in ROS content, ECM expression, and myofibroblast 
induction further emphasize this point. 
 
5.5 Summary of the Studies 
 This study has aimed to characterize the vasculature during the process of aging, 
with a conscious focus on the vascular adventitia. The present study has presented data 
regarding the age-dependent change in vascular structure, function, morphology, and 
protein expression in the thoracic aorta, mesenteric arteries, and pudendal arteries. The 
data presented has demonstrated that the vascular adventitia is an active participant in the 
extensive changes that occur in the vasculature with increasing age. It has been shown 
clearly that the vascular adventitia grows in thickness and in overall cell size with 
increasing age, at a rate that matches the growth of the rest of the vessel wall. 
Additionally, proteins expressed in the adventitia can potentially influence the rest of the 
vessel wall not only by providing enhanced stiffness and structural support, but also 
through the generation of signalling molecules that influence vascular tone, cell growth, 
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and proliferation. It is clear from the results of this study that the common functional 
alterations occurring concomitantly with vascular aging can be attributed, at least in part, 
to the structural and functional alterations of the vascular adventitia. 
 
5.6 Significance of the Studies 
 The results of this study have clearly described for the first time the structural and 
functional alterations that occur in the vascular adventitia with aging. Most notably, this 
study has provided the first direct evidence of the expression of a robust ET system in the 
vascular adventitia that is capable of controlling ET-1-related vascular tone. Furthermore, 
the growth of the adventitial layer with increasing age occurs at a rate that matches the 
growth of the vascular wall, thus allowing the adventitia to influence the structure and 
function of the vascular wall throughout the process of aging. It is clear from these results 
that the influence of the vascular adventitia cannot be ignored when considering vascular 
processes, both in health and disease. 
 
5.7 Limitations and Future Perspectives 
 
5.7.1 Limitations of the Studies 
 
5.7.1.1 Immunofluorescence Detection of Protein Expression in Formalin-Fixed 
Paraffin-Embedded Tissue Sections 
 A commonly held perception of molecular biologists is that formalin fixation of 
tissues precludes the utilization of immunofluorescence as a protein detection method 
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since aldehyde fixatives cause cross-linking of cellular proteins to enhance stability, but 
which also leads to a high degree of autofluorescence (Robertson, Savage, Reis-Filho, & 
Isacke, 2008). This autofluorescence can mask the fluorescence of tagged antibodies 
bound to proteins of interest, making it very difficult to determine what the real protein 
expression level of a tissue is. However, numerous studies have published reports of 
useful, optimized methods for utilizing immunofluorescence in formalin-fixed tissue 
(Baschong, Suetterlin, & Laeng, 2001; Bataille, et al., 2006; Mason, Micklem, & Jones, 
2000; Robertson, et al., 2008; Suetterlin, Baschong, & Laeng, 2004; Viegas, Martins, 
Seco, & do Carmo, 2007). Furthermore, antigen retrieval techniques can be employed to 
reverse the cross-linking caused by formalin fixation, thereby eliminating 
autofluorescence issues. Most commonly this can be achieved through the use of 
alcoholic or aqueous solvents to reduce the aldehyde cross-link bonds, both of which 
were employed in this study. Additionally, measures were taken to ensure that the 
fluorescence observed in the tissues was caused by the fluorescent probe through the use 
of negative control samples. In this case, normal autofluorescence was reduced to nil, 
verifying the validity of the method. 
 
5.7.1.2 Protein Expression/ Vessel Function Relationship 
 Given the chosen method of studying these vessels (formalin-fixed paraffin-
embedded tissue sections), it would be impossible to detect changes in vessel dynamics 
such as constriction and dilation. Therefore, the only functional data we can collect are 
purely circumstantial and indirect. We can surmise that with an overall increase in the 
thickness of the vessel wall, and an enhanced expression of key proteins, the vessel 
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would gain the ability to be far more reactive. However, without direct functional data, 
these assumptions remain purely speculative. Further study is warranted to determine the 
direct functional implications of the broad changes observed to occur with increasing age 
in this study. 
 
5.7.1.3 Isolation of the Vascular Adventitia 
 A common challenge in studying the vascular adventitia has been the isolation of 
this tissue from the rest of the vessel wall. Primary cell culture is an attractive means 
since we and others have shown that adventitial fibroblasts grow well in culture (An, et 
al., 2006; Che, et al., 2008; Jenkins, et al., 2007). However, with no specific cell marker 
available to positively identify fibroblast cells in culture, it becomes increasingly difficult 
to ascertain the true origin of cultured adventitial fibroblasts. Additionally, there are key 
differences in the activity of adventitial cells in situ in the vessel wall and plated in 
culture, making inferences made about vascular biology from cultured adventitial 
fibroblasts difficult to make. Furthermore, the close and tight association of the 
adventitial layer with the rest of the vessel wall makes physical separation exceedingly 
difficult to perform without damaging important cell structures. Thus, the best method for 
observing the vascular adventitia available for this study remains formalin-fixed paraffin 
embedded tissue sections. 
 
5.7.1.4 Potential Confounding Effects of Obesity 
 The animals used in this study exhibited a steady increase in body weight at each 
time point examined (Table A-1). Since the animals were given free access to food and 
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water, it is possible that the older animals may have developed the onset of obesity. 
However, examining the effects of body weight independently of age is not possible in 
this study since the age and body weight of the animals are so highly correlated that 
examining both age and body weight in one statistical model would result in a high 
degree of collinearity and highly unstable estimates of true effect. Unfortunately this is a 
limitation of the study design, and in order to examine the independent effects of age and 
body weight, one would need separate cohorts of obese-prone and obese-resistant animals 
at each time point. Alternatively, caloric restriction could be employed for sub-groups of 
animals to achieve a wider variation in body weight among each of the individual age 
cohorts. 
 
5.7.2 Future Perspectives 
 
5.7.2.1 Caloric Restriction in Aging 
 Caloric restriction has been shown by numerous studies to prolong lifespan, 
improve cellular oxidative damage, and result in far less age-related pathology (Choi & 
Yu, 1998; Csiszar, et al., 2009; Hannan, Heaton, & Adams, 2007; Masoro, 2005). In 
addition, caloric restriction has been shown to have a positive impact on such important 
cardiovascular factors such as endothelial function (H. Yang, Shi, Story, Richardson, & 
Guo, 2004), cerebral blood flow (Lynch, et al., 1999), age-related arteriosclerosis 
(Chiarpotto, Bergamini, & Poli, 2006), and serum prostaglandin expression (Choi & Yu, 
1998). Furthermore, it should be noted that the red wine polyphenol resveratrol has been 
shown to produce similar effects (Chao, et al., 2005; Pearson, et al., 2008). However, the 
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effects of a caloric restriction regimen on the structure and function of the vascular 
adventitia has never been addressed. Given the vast changes observed in the vascular 
adventitia with increasing age in this study, caloric restriction could potentially serve as a 
simple, effective treatment against the age-related detriments to the vascular adventitia. 
 
5.7.2.2 Adventitial Endothelin System Activity 
 The present study has provided the first clear evidence of ET system protein 
expression in the vascular adventitia. However, due to the limitation in the isolation of 
the adventitia, the present study has not been able to show whether or not this system is 
definitely active, or furthermore able to influence the rest of the vessel wall. It is possible 
to constitutively activate or inactivate the expression of endothelin system proteins in a 
particular tissue or cell type (Amiri, et al., 2004; Kelland, et al., 2010; Kisanuki, et al., 
2010). Altering the expression of ET-1 specifically in the endothelium, or vascular 
smooth muscle, would allow one to determine the net effect of ET-1 expression in the 
vascular adventitia. Thus, we may be able to gain knowledge into the role of the 
adventitia in mediating ET-related vascular diseases. 
 
5.7.2.3 Disease Models Exhibiting Enhanced Endothelin System Expression 
 Given the present demonstration of intense expression of ET system proteins in 
the vascular adventitia, one can only wonder as to the impact that the adventitia may have 
on ET- related vascular diseases. Previous studies have shown an elevation in the 
expression and release of ET-1 in the DOCA-salt hypertensive rat model (Lariviere, et 
al., 1995) and the Ang II infused model (Barton, Shaw, d'Uscio, Moreau, & Luscher, 
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1997). Furthermore, data from our own lab has shown that Ang II stimulation in 
adventitial fibroblasts induces expression and release of ET-1 (An, et al., 2006). Given 
these lines of evidence, it would be interesting to learn if ET-1 expression in the vascular 
adventitia is similarly enhanced in vivo in these disease models, which may provide a 
novel approach to therapy in hypertension. 
 
5.8 Conclusion 
 The results of the present study have provided a detailed characterization of the 
vascular adventitia in aging. Combining the structural and functional changes occurring 
in the aging adventitia, it is clear that the adventitia has the capability to profoundly 
influence normal vascular function in aging. Additionally, the adventitia is clearly 
implicated in the initiation and progression of numerous age-related vascular diseases, 
such as arteriosclerosis and hypertension. Thus it is clear that the vascular adventitia can 
no longer be ignored when concerning vascular function, both in health and disease. 
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Appendix 
Table A-1. Body and heart weights. 
  
Measurement 15 wks 30 wks 50 wks 80 wks 
Body Weight (g) 347.0 ± 6.9b,c,d 602.7 ± 9.0a,d 681.3 ± 24.6a 765.0 ± 22.9a,b 
Left Ventricle Weight (g) 0.70 ± 0.02b,c,d 1.04 ± 0.04a 1.06 ± 0.01a 1.13 ± 0.02a 
Right Ventricle Weight (g) 0.19 ± 0.01b,c,d 0.29 ± 0.01a 0.27 ± 0.01a,d 0.30 ± 0.01a,c 
  
Mean ± SEM; ap<0.05 vs. 15 wks; bp<0.05 vs. 30 wks; cp<0.05 vs. 50 wks; dp<0.05 vs. 80 wks 
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Figure A-1. Immunofluorescence negative control. Rat aortas aged 15 weeks (A), 30 weeks (B), 50 
weeks (C), and 80 weeks (D) displayed very little non-specific binding of the ET-1 antibody after peptide 
competition. Thoracic aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 
5μm. Samples were then incubated with an anti-ET-1 antibody which had previously been incubated with 
the ET-1 peptide. Samples were then incubated with a secondary antibody conjugated to Alexa Fluor 488 
(green). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent 
microscope with a 40X objective lens. Scale bars represent 100μm. 
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Figure A-2. von Willebrand factor protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 
30 weeks (B), 50 weeks (C), and 80 weeks (D) displayed some von Willebrand factor (vWF), a specific 
endothelial cell marker, in the endothelium. vWF was not expressed in either the medial or adventitial 
layers. Thoracic aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. 
Samples were then immunostained for vWF and detected with a secondary antibody conjugated to Alexa 
Fluor 488 (green). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon 
fluorescent microscope with a 40X objective lens. Scale bars represent 100μm. 
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Figure A-3. CD4 protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks (B), 50 
weeks (C), and 80 weeks (D) displayed very little CD4 protein, a specific cell marker for macrophages. 
Thoracic aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples 
were then immunostained for CD4 and detected with a secondary antibody conjugated to Alexa Fluor 546 
(red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent 
microscope with a 40X objective lens. Scale bars represent 100μm.  
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Figure A-4. c-kit protein localization in the aortic wall. Rat aortas aged 15 weeks (A), 30 weeks (B), 50 
weeks (C), and 80 weeks (D) displayed very little c-kit protein, a specific cell marker for stem cells. 
Thoracic aortas were isolated, formalin fixed, embedded in paraffin and serially sectioned at 5μm. Samples 
were then immunostained for c-kit and detected with a secondary antibody conjugated to Alexa Fluor 546 
(red). Nuclei were visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent 
microscope with a 40X objective lens. Scale bars represent 100μm.  
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Figure A-5. Caspase-3 positive control. An aorta isolated from a normotensive rat (A) displays very little 
positive staining for caspase-3 (green). Similarly, an aorta isolated from a hypertensive rat (B) very little 
positive staining for caspase-3 (green). Thoracic aortas were isolated, formalin fixed, embedded in paraffin 
and serially sectioned at 5μm. Samples were then immunostained for 3-nitrotyrosine and detected with a 
secondary antibody conjugated to Alexa Fluor 488 (green). Nuclei were visualized using DAPI (blue). 
Samples were viewed under a Nikon fluorescent microscope with a 40X objective lens. Scale bars 
represent 100μm. 
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Figure A-6. 3-Nitrotyrosine positive control. An aorta isolated from a normotensive rat (A) displays very 
little positive staining for 3-nitrotyrosine (green). However, an aorta isolated from a hypertensive rat (B) 
displays significant positive staining for 3-nitrotyrosine (green). Thoracic aortas were isolated, formalin 
fixed, embedded in paraffin and serially sectioned at 5μm. Samples were then immunostained for 3-
nitrotyrosine and detected with a secondary antibody conjugated to Alexa Fluor 488 (green). Nuclei were 
visualized using DAPI (blue). Samples were viewed under a Nikon fluorescent microscope with a 40X 
objective lens. Scale bars represent 100μm. 
 
